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 The ubiquitous bacterium P. aeruginosa is an important human pathogen that 
causes devastating infections in immunocompromised patients and chronic infections in 
cystic fibrosis patients.  The ability of P. aeruginosa to cause such debilitating infections 
is in part due to its three known cell-to-cell signals.  The Pseudomonas quinolone signal 
(PQS, 2-heptyl-3-hydroxy-4-quinolone) is one of these intercellular signals and is 
required for virulence in multiple models of infection.  The pathway needed for 
biosynthesis of PQS is also responsible for the production of at least 56 other 4-
quinolone molecules.  The synthesis of PQS, as well as the other 4-quinolone 
molecules, requires the condensation of anthranilate and a β-keto fatty acid.  The 
precursor anthranilate is an important branch point molecule as it can be converted into 
PQS (or other metabolites), used for tryptophan synthesis, or catabolized as a carbon 
and nitrogen source.  In P. aeruginosa, anthranilate is synthesized by either the 
 
 
breakdown of tryptophan through the kynurenine pathway or the conversion of 
chorismate via one of the two anthranilate synthases, TrpEG and PhnAB.  The 
kynurenine pathway and the secondary anthranilate synthase PhnAB have been shown 
to provide anthranilate for the production of PQS.  Our laboratory previously showed 
that the kynurenine pathway is the main source of anthranilate for PQS production in 
the presence of tryptophan, while PhnAB provides anthranilate under nutrient limiting 
conditions.  In this work we aimed to gain a better understanding of the regulation of 
each of these metabolic routes to anthranilate.  We described the transcriptional 
regulator KynR that is responsible for the upregulation of the kynurenine pathway genes 
in the presence of kynurenine.  We also discovered that a single nucleotide change at 
nucleotide 1041 in pqsC resulted in a new transcript and the upregulation of pqsD, 
pqsE, and phnAB transcripts.  This work provides insight into the regulation of 
anthranilate synthesis and the production of PQS. 
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 CHAPTER ONE:  INTRODUCTION 
 This work has developed around the discovery of the biosynthetic route for the P. 
aeruginosa cell-to-cell signal PQS (Pseudomonas Quinolone Signal).  PQS is 
synthesized via a multistep reaction involving the condensation of the two precursors, 
anthranilate and a β-keto fatty acid.  The precursor anthranilate is of interest because 
though the pathways that produce anthranilate are known, the regulation of the 
pathways is not well understood.  Three pathways in P. aeruginosa produce 
anthranilate, yet only two of the pathways provide anthranilate used for the biosynthesis 
of PQS (37).  The first pathway is the kynurenine pathway and the second is mediated 
by the anthranilate synthase PhnAB.  These two pathways alternatively produce 
anthranilate when grown under different nutrient conditions and each is uniquely 
regulated.  The goal of the current research was to understand the regulation of each 
pathway with regard to its role in the production of PQS.  To fully recognize the 
significance of this research it is important to first have a basic understanding of P. 
aeruginosa as a human pathogen, its ability to communicate using cell-to-cell signaling, 
and the biosynthetic pathways for anthranilate.  
1.1 Pseudomonas aeruginosa is an important human pathogen 
The opportunistic pathogen P. aeruginosa is a ubiquitous, Gram-negative, 
facultative anaerobe that is able to flourish under environmental stress and nutrient 
limiting conditions.  Due to the adaptive nature of P. aeruginosa, it is able to cause a 
wide range of infections from bacterial keratitis (113) to infections in the 
immunocompromised (72).  P. aeruginosa is a common nosocomial pathogen and is 
known to cause 16.3% of ventilator-associated pneumonia, 10.0% of catheter-   
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associated urinary tract infections, and 5.6% of surgical site infections (50).  Burn 
patients are also commonly infected with P. aeruginosa, and these infections can lead 
to bacterial sepsis, pneumonia, and an increased mortality rate (26).  The chronic 
infection of P. aeruginosa in the lungs of cystic fibrosis (CF) patients is especially 
devastating.  The majority of CF patients are infected by the age of 3 and over time, P. 
aeruginosa develops into a mucoid, multi-drug resistant phenotype that makes 
eradication nearly impossible (10).  Chronic P. aeruginosa infections lead to decreased 
respiratory function, eventually resulting in increased morbidity and mortality in CF 
patients (73, 112).  The ability for P. aeruginosa to cause such a wide-range of 
infections makes it an important bacterium to study and understand.  
 Treatment for P. aeruginosa infections is through multi-antibiotic drug treatment, 
yet with the ever-increasing antibacterial resistance of P. aeruginosa strains this 
approach may not be effective in the near future.  Treatment of CF patients consists of 
a multi-antibiotic approach that includes inhaled tobramycin or colistin along with oral 
ciprofloxacin (112).  Current studies suggest elimination of the bacterial infection from 
children is possible through a multi-drug treatment regimen, but long term eradication of 
P. aeruginosa from these patients is not expected because of continued environmental 
exposure that leads to reinfection (112).  The antibiotic treatment in older CF patients is 
mildly effective until the multi-drug resistant phenotype appears in the lung (10).  The 
treatment for ventilator-associated pneumonia is also a multi-drug approach and has 
decreased the ventilator-associated pneumonia mortality rate from 35% to 29% in some 
reported cases (49, 83).  Though multi-drug therapies have benefited patients, P. 
aeruginosa is rapidly evolving, and multi-drug resistance has greatly increased over the 
3 
years.  Current studies suggest that 31% of P. aeruginosa isolates in the United States 
are fluoroquinolone resistant and increasing resistance has been noted worldwide for 
multiple classes of antibiotics (49, 50, 104).  Hospital isolates from 2006-2007 revealed 
that 10% of P. aeruginosa strains were resistant to three classes of antibiotics (56), 
suggesting that nosocomial infections will be increasingly difficult to treat in the future.  
New therapies to treat P. aeruginosa infections are in high demand.  The development 
of novel treatment and prevention strategies is focused on targeting biosynthetic 
pathways through drug therapies and using extracellular structures to make vaccines.  
Current therapies in development include vaccines with P. aeruginosa outer-membrane 
proteins OprI/OprF or purified flagellin protein, immunoglobulin research, and new 
antibiotic delivery systems (1, 9, 136).  
1.2 Quorum Sensing in Pseudomonas aeruginosa 
 Bacterial communication via quorum sensing has been well described in many 
species and occurs through multiple mechanisms. Three cell-to-cell signaling systems 
in P. aeruginosa are utilized to precisely activate expression of virulence factors and 
quickly adapt to the changing environmental conditions.  P. aeruginosa utilizes two acyl 
homoserine lactone (AHL) signals and one quinolone based signal.  The three signal 
systems employed by P. aeruginosa include the las, rhl, and PQS systems. (Figure 1.1) 
(19).  The las and rhl regulons are considered true quorum sensing systems and 
synthesize N-acylhomoserine lactone signals (96).  The AHL systems function by 
producing the signal at a basal rate and as the population increases the signal 
concentration also increases (96).  Once the signal reaches an intracellular threshold 
concentration, it will bind to the transcriptional regulator (“R” protein) and then regulate  
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Figure 1.1: The three known cell-to-cell signals in P. aeruginosa.  A) 3-oxo-C12-HSL B) 
C4-HSL C) 2-heptyl-3-hydroxy-4-quinolone (PQS) (95). 
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gene expression accordingly (96).  The signal for the las system is N-3-oxo-dodecanoyl 
homoserine lactone (3-oxo-C12-HSL), which is produced by the signal synthase LasI, 
and binds to the transcriptional regulator LasR (42, 92).  The rhl system is similar to the 
las system, where the signal N-butyryl homoserine lactone (C4-HSL) is produced by 
RhlI, and binds to the transcriptional regulator RhlR (84, 85, 93).  The two systems are 
arranged in a hierarchy where LasR-3-oxo-C12-HSL positively regulates the rhl system, 
as well as the quinolone-based system (63, 96).  Together, the las and rhl systems 
regulate up to 10% of the P. aeruginosa genome, suggesting that the quorum sensing 
systems coordinate a highly influential signal cascade (107, 122).  This influence is 
further shown by the attenuation of P. aeruginosa las and rhl signal system mutants in 
multiple infection models (27).  
1.3 The Pseudomonas Quinolone Signal 
1.3.1 The biosynthesis and regulation of PQS 
 The third cell-to-cell signal was discovered in 1999 by Pesci et al. and was termed 
the Pseudomonas Quinolone Signal (PQS) (95).  PQS was detected when spent culture 
media from wild-type P. aeruginosa activated a transcriptional fusion of lasB (encoding 
for the virulence factor elastase) in a lasR mutant (95). This suggested that a novel 
signal could activate lasB in the absence of the known regulator LasR (95).  The signal 
was purified and identified to be 2-heptyl-3-hydroxy-4-quinolone (95).  The structure 
was confirmed when synthetic PQS activated lasB-lacZ in a similar manner to natural 
PQS (95). The bioassay results also suggested that PQS required the las system for 
production of the signal and the rhl system for bioactivity (95).  The role of PQS in the 
quorum sensing hierarchy was further defined by testing lasR, lasI, rhlR, and rhlI 
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transcriptional gene fusions in the presence and absence of PQS.  The results 
suggested that PQS positively influences the signal synthase RhlI and, to a lesser 
degree, LasR and RhlR (81).  This complicates the idea of a quorum sensing hierarchy 
and leads us to believe that each of the signals have influence on the other systems 
performing checks and balances to ensure the precise regulation of quorum controlled 
genes.  McKnight et al. also showed that maximal production of PQS occurs during 
stationary phase, unlike true quorum sensing molecules that reach maximal 
concentration during late exponential phase (81).  The positive influence of PQS on the 
activity of AHL quorum sensing genes and the late stationary phase production 
suggests that PQS does not sense cell density, but is a link between the las and rhl 
quorum sensing systems (81).  
 Since the initial identification of PQS, the genes required for the biosynthesis of 
this molecule have been identified.  The PQS biosynthetic locus (Figure 1.2) is 
composed of a five gene operon, pqsABCDE, that contains the genes responsible for 
the synthesis of 4-quinolone compounds (pqsABCD) (80).  The last gene in the operon, 
pqsE, encodes a putative metallo-β-lactamase/hydrolase that is not required for PQS 
biosynthesis, but rather for the production of PQS-controlled virulence factors (38).  
Directly downstream from pqsE is the phnAB operon that encodes an anthranilate 
synthase.  Lastly in the biosynthetic gene cluster is pqsR, which is convergently 
transcribed from phnAB and encodes the transcriptional regulator that induces the 
expression of the PQS biosynthetic operon.  The final gene required for PQS 
biosynthesis is pqsH and it is located separately on the chromosome.  The PQS 
biosynthetic genes are responsible not only for the production of PQS, but also for at 
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least 56 other 4-hydroxy-2-alkylquinolines (HAQ) produced by P. aeruginosa (67).  
HAQs have multiple roles in P. aeruginosa virulence and understanding the synthesis of 
these molecules could lead to potential drug therapy targets (67).   
 The structural similarity of HAQ and previously described pyo-compounds 
suggested that the synthesis of these molecules required the condensation of 
anthranilate and a fatty acid precursor (21, 66).  The biosynthesis of PQS is diagramed 
in Figure 1.3.  Anthranilate is provided for the production of PQS by two separate 
pathways, the anthranilate synthase phnAB or the kynurenine pathway (37).  Calfee et 
al. first showed that anthranilate was a precursor to PQS and Bredenbruch et al. 
confirmed that PQS was produced via a “head to head” condensation reaction between 
anthranilate and a β-keto fatty acid (7, 11).  The first four genes in the PQS biosynthetic 
operon, pqsABCD, are responsible for the production of the PQS precursor HHQ (4-
hydroxy-2-heptylquinoline), as well as the production of 56 other quinolones (67).  The 
synthesis of HHQ occurs via PqsA, an anthranilate CoA ligase that activates 
anthranilate, and PqsD, which condenses the fatty acid with the activated thioester of 
anthranilate to make the precursor HHQ (5, 18).  PqsB and PqsC are necessary for 
PQS biosynthesis, though it is unclear exactly what role they play in the production of 
PQS (47).  The final step in PQS biosynthesis occurs via PqsH, a FAD-dependent 
monoxygenase that hydroxylates HHQ to make PQS (106). Together, these proteins 
produce may quinolone molecules that influence virulence and aid in the survival of P. 
aeruginosa.   
 As explained above, the production of PQS is highly coordinated and requires the 
expression of multiple genes.  The role of traditional AHL quorum sensing regulators   
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Figure 1.2. Proposed pathway for PQS biosynthesis.  Anthranilate is activated by PqsA 
to form anthraniloyl-CoA, and this is condensed with 2-oxo-decanoyl-ACP which is 
recruited from the fatty acid biosynthetic pathway. The recruitment and condensation 
are postulated to be catalyzed by PqsB, PqsC, and PqsD. The resulting 2-heptyl-4-
quinolone is then hydroxylated at the third carbon by the PqsH monooxygenase to 
produce PQS. Adapted from the figure published by Coleman et al. (18) 
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and the PQS induced transcriptional regulator PqsR are well described.  The AHL 
quorum sensing regulators LasR and RhlR regulate quinolone production in a 
counterintuitive loop, with LasR and RhlR respectively upregulating and downregulating 
PQS biosynthesis (80, 81, 95, 121).  The regulator LasR directly induces the expression 
of pqsR, pqsA, and pqsH and LasR binding boxes were identified in the promoters of 
these genes (43, 80, 121, 127).  LasR is important for the induction of PQS biosynthetic 
genes, yet a mutation in lasR only delays the expression of PQS genes, indicating that 
the PQS biosynthetic genes are transcribed despite the absence of LasR (31).  While 
LasR has a positive effect on PQS gene regulation, RhlR has a negative impact on the 
transcription of PQS related genes.  This was shown both by a 50% increase in pqsR 
transcription in an rhlI mutant, as well as increased transcription of pqsA (80).  Two 
predicted las/rhl binding boxes were identified in the pqsA promoter, and studies 
suggested that both LasR and RhlR could bind to each box resulting in either activation 
or repression of the transcription of pqsA (43, 132).  The transcriptional regulator PqsR 
is activated by PQS to positively regulate gene expression (29, 95, 131).  PqsR is 
necessary for the production of 4-quinolone based molecules (29, 41, 80).  Both 
microarray and transcriptional fusion experiments have shown the importance of PqsR 
on both pqsABCDE and phnAB operons expression (28, 29, 80).  Direct binding of 
PqsR to the pqsA promoter has been shown by both Wade et al. (121) and Xiao et al. 
(132), indicating the direct importance of PqsR to the production of 4-quinolone 
molecules.  In addition to quorum sensing regulation, other factors have been found to 
influence PQS regulation.  These include PmpR, a negative regulator of pqsR, and 
environmental factors such as iron and phosphate levels (55, 71, 86).  Overall, the 
10 
regulators of PQS genes work in concert to ensure the correct timing of PQS production 
and PQS-mediated gene regulation.  
1.3.2 The bioactivity and virulence of PQS 
 PQS and the other 56 HAQs produced by P. aeruginosa are extremely important 
to the survival of the bacteria through the bioactivity of these molecules.  PQS induces 
the production of membrane vesicles and is incorporated into the bacterial outer 
membrane and membrane vesicles at high concentrations (77, 78).  The PQS-
containing membrane vesicles are also bioactive as they are able to induce PQS-
mediated virulence factors in a PQS null strain (77). The membrane vesicles are 
believed to protect PQS from degradation when grown in the environment, thus 
ensuring that PQS cell-to-cell signaling would still be active (127).  The induction of 
rhamnolipids, a virulence factor controlled by PQS and the quorum sensing regulator 
RhlR, is important for PQS bioactivity because the presence of rhamnolipids increases 
the solubility and activity of the molecule (121).  PQS is also able to chelate ferric iron 
and the addition of PQS to cultures induces siderophore production and induction of 
siderophore-mediated iron transport systems (7, 30).  The production of PQS is also 
controlled by the iron-inducible regulator Fur and small RNAs PrrF1 and PrrF2 (86).  
Lastly the production of over 56 HAQ molecules is advantageous to P. aeruginosa as 
some of the molecules exhibit antibiotic properties (47).  The HAQs produced by P. 
aeruginosa are able to inhibit the growth of Staphylococcus aureus, Staphylococcus 
epidermidids, and Candida albicans, which would important during infections, as it 
would eradicate the other microorganisms (74, 77).  Overall, it is clear that the 
bioactivity of PQS and the 56 other HAQs produced by the PQS pathway are important 
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for P. aeruginosa survival.   
 PQS affects P. aeruginosa virulence in two ways.  First it activates virulence factor 
production.  PQS is essential for virulence in Caenorhabditis elegans, Drosophila 
melanogaster, lettuce leaf, and multiple rodent infection models (28, 41, 64, 101, 130).  
The influence of PQS on the virulence of P. aeruginosa is also possible during infection 
of CF patients, as PQS was directly extracted from CF patient sputum and the 
mucopurulent airway fluid of a freshly resected CF lung (19).  It also was produced by 9 
of 10 P. aeruginosa isolates from CF patients (19).  In addition, Guina et al. showed an 
overall deregulation of PQS production by P. aeruginosa isolates from infant CF 
patients, with strains exhibiting a 7-15 fold increase in PQS production (44).  The 
importance of PQS in infections can be attributed to the positive regulation of many 
virulence factors such as pyocyanin, elastase, rhamnolipids, PA-IL lectin, RpoS, C4-
HSL, and biofilm production (31, 41, 64, 81, 91, 95).  Both elastase and pyocyanin are 
directly attributed to aiding in the immune system modulation by P. aeruginosa (28, 31, 
81, 95).  Elastase cleaves collagen, immunoglobulins, complement, and fibronectin (31).  
Pyocyanin causes severe damage to the epithelial cells of the lung and is directly 
responsible for a 10% increase of neutrophils, macrophages, and lymphocytes during a 
P. aeruginosa infection (31, 60, 128).  PQS also causes a directly increased apoptosis 
and decreased cell viability in two mouse cell lines at physiological concentrations (5 to 
10 uM) (12).  Finally, PQS directly affects the immune system by downregulating the 
innate immune response through both nuclear factor kappa B (NF-KB) and hypoxia-
inducible factor 1 (HIF-1) (58, 65).  As an adaptive human pathogen P. aeruginosa 
employs PQS to aid in evading the immune system through virulence factor regulation 
12 
and modulation of host factors, thus making its biosynthesis a very important pathway to 
understand.  
1.4  The Pathways to Anthranilate 
The production and degradation of anthranilate is an important branch point in P. 
aeruginosa, as it balances the production of virulence factors via PQS and growth of the 
bacterium by being broken down into tricarboxylic acid cycle intermediates (17).  Since 
the identification of anthranilate as the precursor of PQS the importance of 
understanding both the pathways that synthesize and degrade anthranilate has become 
clear.  Anthranilate is synthesized by three main pathways in P. aeruginosa, the 
kynurenine pathway and the two anthranilate synthases TrpEG and PhnAB (Figure 1.3) 
(37, 45).  Other enzymes, PhzE1, PhzE2, PabB, and PchA, are anthranilate synthase 
homologs, but are not responsible for the cellular pool of anthranilate (25, 34, 35).  The 
existence of multiple pathways to synthesize anthranilate further supports the 
importance of this molecule to P. aeruginosa survival, and these three pathways will be 
discussed in depth in the following paragraphs.  The degradation of anthranilate into 
pyruvate is via AntABC and CatBCA, and the expression of these genes is tied into 
quorum sensing and iron availability (17, 86).  The balance between production and 
degradation is maintained via similar regulators including quorum sensing and iron 
regulated small-RNA’s, autoinduced regulators, and yet to be identified regulators (17, 
29, 35, 86).  The complex nature of the anthranilate branch point makes understanding 
the production and regulation of this key molecule, as well as its role in PQS synthesis, 
our priority. 
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Figure 1.3 : The three biochemical pathways to anthranilate in P. aeruginosa 
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1.4.1 The Kynurenine Pathway 
The kynurenine pathway is responsible for the oxidative catabolism of tryptophan 
to anthranilate and has been well described in eukaryotes (62).  The ability of a 
bacterium to utilize this amino acid as a carbon and nitrogen source is advantageous in 
the environment, as it would preserve energy for the bacteria due to the energy 
expense to synthesize tryptophan and further decrease the concentration of free 
tryptophan for use by other organisms.  The existence of the kynurenine pathway was 
originally predicted in prokaryotes in 1943 and verified in Pseudomonad species during 
the early 1950’s (82, 110).  In 1962, a strain of P. aeruginosa was shown to catabolize 
L-tryptophan, D- tryptophan, and kynurenine into anthranilate via the kynurenine 
pathway and biochemically confirmed the pathway in this species of Pseudomonas (4).  
The anthranilate branch of the kynurenine pathway is pictured in Figure 1.3 and 
consists of three enzymes: tryptophan 2,3-dioxygenase (kynA), kynurenine 
formamidase (kynB), and kynureninase (kynU) (62).  In 2003, the eukaryotic genes for 
kynA and kynU were used to search for genetic homologs in bacteria, and this 
comparative genomics approach provided putative genetic homologs in multiple 
bacteria (62).  At the time of the analysis the eukaryotic kynB was not sequenced and 
putative prokaryotic kynB genes were identified by searching predicted protein functions 
near the other kynurenine pathway genes (62).  A conserved gene was identified in 
many of the bacteria near the kynurenine pathway genes and was suggested to encode 
KynB (62).  The predicted KynB protein from Ralstonia metallidurans was purified and 
enzymatically converted formyl-kynurenine to kynurenine in vitro, confirming that the 
predicted gene encoded a kynurenine formamidase (62). The entire pathway in R. 
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metallidurans was confirmed to convert tryptophan to anthranilate and proved the 
predicted genes encoded a functional kynurenine pathway (62).  The genetic 
identification of the kynurenine pathway in P. aeruginosa confirmed the earlier 
biochemical findings in the 1960’s.  The genetic organization of the kynurenine pathway 
is pictured in Figure 1.4.  The kynA gene is located separately on the chromosome, 
while kynB and kynU are encoded in a putative two or three gene operon that may also 
contain an amino acid permease (PA2079) (www.pseudomonas.com).  We have shown 
that the kynurenine pathway mutants cannot grow on defined media with tryptophan as 
the sole carbon source indicating that this is the only pathway that can catabolize 
tryptophan in P. aeruginosa (Figure 2.2) (59).  The identification of this pathway 
provides for a unique alternative for the synthesis of the branch point molecule 
anthranilate. 
The importance of the kynurenine pathway in P. aeruginosa virulence was 
indicated when it was identified as the major pathway of anthranilate for PQS 
production.  Chugani and Greenberg also have suggested the kynurenine pathway is a 
main source of anthranilate for nutritional acquisition for P. aeruginosa (17).  The role of 
the kynurenine pathway in PQS production was suspected due to the increase in PQS 
when P. aeruginosa was grown in tryptophan-supplemented media (62, 91).  To 
investigate if the kynurenine pathway provided anthranilate for PQS production, 
radiolabeled tryptophan was added to growing cultures and PQS extractions were 
performed (37).  The results indicated that [3H]-tryptophan was incorporated into PQS in 
wild-type PAO1 (Figure 1.5A) (37).  The lack of PQS production in the kynurenine 
pathway mutants was surprising because P. aeruginosa contains two other pathways  
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Figure 1.4: The genetic organization and enzymatic reactions of PhnAB and the 
kynurenine pathway.  The color of the gene corresponds to the enzymatic reaction 
depicted by the colored arrow.  
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Figure 1.5: PQS extractions in kynurenine pathway and phnAB mutants. A) and B) PQS 
extractions of multiple P. aeruginosa strains grown in the presence of [3H]-Tryptophan 
Photograph (A) and autoradiograph (B) of TLC. Lanes 1 contain 0.001 µCi L-[5-
3H]tryptophan, and lanes 8 contain 25 ng synthetic PQS. Lanes 2 to 6 contain culture 
extracts from strains PAO1, PJF-KA1 (ΔkynA), PJF-KB1 (ΔkynB), PJF-KU1 (ΔkynU), 
and PJF-PHNA1 (ΔphnA), respectively.  Lanes 7 contain an extract of uninoculated 
culture medium.  C) PQS extracts from growth in minimal media supplemented with 
water (W), 1 mM L-tryptophan (T), or 0.5 mM anthranilic acid (AA) were analyzed by 
TLC.  Lanes 1 to 3 contain extracts from strain PAO1 cultures, lanes 4 to 6 contain 
extracts from strain PJF-KA1 cultures, and lanes 7 to 9 contain extracts from strain PJF-
PHNA1 cultures. Lane 10 contains an extract from a culture of PJF-PHNA1 carrying 
vector plasmid pUCP22, and lane 11 contains an extract from a culture of PJF-PHNA1 
carrying phnAB expression plasmid pJF100. Lane 12 contains 25 ng of synthetic PQS, 
and lane 13 contains 34 ng of anthranilic acid. These data were originally published by 
Farrow  and Pesci in 2008 (37).  
C 
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that can produce anthranilate (35, 37), yet the results showed the kynurenine pathway 
is the main source of anthranilate for PQS production when grown in complex media.  
The importance of these genes in the production of PQS and other HAQs was also 
demonstrated when the kynurenine mutants exhibited a decreased ability to kill S. 
aureus (37).  Finally it is suspected that the kynurenine pathway would be important for 
nutritional acquisition and virulence factor production in the CF lung due to the 
increased concentration of amino acids, as well as the production of proteases to 
liberate tryptophan from proteins within sputum (2, 48, 90, 115). 
 As the kynurenine pathway was found to be a major source of anthranilate for the 
synthesis of PQS, elucidating the regulation of this pathway would be beneficial for 
further understanding PQS production.  Previous enzymatic studies in Pseudomonas 
aureofaciens and Bacillus megaterium suggested that the kynurenine pathway in P. 
aeruginosa would be positively influenced by the presence of tryptophan or kynurenine 
(6, 105).  Transcriptional lacZ fusions of the kynA (pJFO3) and kynB (pJFO1) promoters 
were analyzed in wild-type P. aeruginosa (PAO1) and PJF-KA1 (a kynA mutant) to 
investigate the role of tryptophan, kynurenine, and anthranilate in the expression of the 
kynurenine pathway (Figure 1.6) (6, 37).  The results indicated that kynA and kynB have 
similar regulation, and are induced in the presence of tryptophan and kynurenine in 
strain PAO1 (37).  To determine if tryptophan or kynurenine induced the expression of 
kynA and kynB transcriptional fusions, the two fusions were tested in the kynA mutant 
strain, which is unable to break down tryptophan into kynurenine pathway intermediates 
(Figure 1.6)(37).  In this strain, the expression of both fusions was only induced in the 
presence of kynurenine, and not tryptophan (37).  Also, these experiments showed that  
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Figure 1.6: Kynurenine increased the transcription of kynA and kynB.  β-Galactosidase 
activity of kynA-lacZ (pJF03) (A) or a kynB-lacZ  (pJF01) (B) in strains PAO1 and PJF-
KA1 was assayed in cultures grown in LPSM supplemented with either water (black 
bars), 1 mM L-tryptophan (checkered bars), 1 mM L-kynurenine (light gray bars), or 1 
mM anthranilic acid (white bars) for 24 h.  For reference, the striped bars represent data 
derived from unsupplemented cultures grown in PTSB medium. β-Gal activity is 
presented in Miller units as the mean±σn-1 of results from duplicate assays from at least 
three separate experiments.  As a reference, parental vector plasmid pLP170 in strain 
PAO1 cultured in minimal media supplemented with water produced 814 ± 292 Miller 
units of β-Gal activity. These data were originally published by Farrow and Pesci in 
2008 (37).  
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neither gene is responsive to anthranilate (Figure 1.6).  The influence of kynurenine on 
the transcriptional expression of the kynurenine pathway genes indicated the possibility 
of a direct transcriptional regulator that was influenced in the presence of this 
metabolite.  A ChIP-chip assay performed with the quorum sensing regulator LasR 
indicated that it directly binds to the kynB promoter region and this was confirmed by an 
electrophoretic mobility shift assay by our lab (unpublished data) (43).  Yet our lab ruled 
out LasR as the major transcriptional regulator of the kynurenine pathway due to the 
small change in β-galactosidase activity of a kynB lacZ fusion in a lasR mutant 
(unpublished data).  In the search for the kynurenine responsive transcriptional 
regulator our lab identified gene PA2082, which encodes a putative transcriptional 
regulator that is divergently transcribed from kynB.  This putative regulator, which we 
have designated KynR, is also located near the kynurenine pathway genes in multiple 
other bacteria (Figure 2.1) (59).  KynR is homologous to Lrp or AsnC-type regulators of 
which many function as feast/famine regulators (FFRP) (135).  FFRPs often induce 
amino acid metabolism genes, and though Lrp has a global regulatory role in E. coli, 
many Lrp-like proteins have more specific roles in regulation (8).  FFRPs typically 
function as dimers and have two functional domains, an N-terminal DNA binding domain 
and a C-terminal assembly domain (135).  These characteristics and the location of 
kynR suggested that kynR could encode the kynurenine responsive transcriptional 
regulator of the kynurenine pathway genes.  The experiments that investigated the 
transcriptional regulator KynR are detailed in Chapter 2. 
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1.4.2 The Anthranilate Synthases TrpEG and PhnAB 
 Anthranilate is typically synthesized within bacteria by an anthranilate synthase.  
Anthranilate synthases are composed of a α subunit and a β subunit.  The α subunit is 
the larger of the two and is responsible for the conversion of chorismate to anthranilate 
(23, 133).  The β subunit provides ammonia from glutamine for the α subunit enzymatic 
reaction in vivo (133).  Typically anthranilate synthases have two levels of tryptophan 
inhibition, at the post-transcriptional and post-translational levels (89, 100, 116).  To 
initially characterize the P. aeruginosa anthranilate synthase, Crawford et al. used a 
plasmid containing P. aeruginosa genes to complement an E. coli tryptophan auxotroph 
(22, 23).  The P. aeruginosa genes provided a five-fold regulatory response to 
tryptophan deprivation and suggested that the plasmid encoded an anthranilate 
synthase (22, 23).  The suspected anthranilate synthase, however, did not exhibit any 
type of tryptophan inhibition (22, 23).  Sequence alignments of the suspected P. 
aeruginosa anthranilate synthase with previously sequenced trpE and trpG from 
Pseudomonas putida suggested that the plasmid encoded an anthranilate synthase that 
differed significantly in sequence and localization on the chromosome (22, 23).  In 1990, 
a series of papers by Essar et al. demonstrated that the anthranilate synthase on the 
plasmid was not the P. aeruginosa TrpEG, but rather contained genes encoding for a 
secondary anthranilate synthase (35, 36).  This was an unexpected find, as the majority 
of bacteria contain only one anthranilate synthase.  The newly identified anthranilate 
synthase was linked to secondary metabolites and the genes were named phnAB (35).  
Together TrpEG and PhnAB are the only two true anthranilate synthases in P. 
aeruginosa and results in a genetic redundancy that provides for uniquely functioning 
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anthranilate synthases, with TrpEG providing the first step in tryptophan synthesis and 
PhnAB supplying anthranilate for PQS production.   
 Tryptophan is the most energetically expensive amino acid to produce and to 
compensate this the production of tryptophan is highly regulated (137). Tryptophan 
synthesis is the result of five separate enzymatic reactions and the first step involves 
the anthranilate synthase TrpEG (45).  The regulation of tryptophan synthesis involves 
multi-level regulation of the anthranilate synthase both at the post-transcriptional and 
post-translational levels.  The trpE and trpGDC operons are regulated by post-
transcriptional tryptophan attenuation in Pseudomonas putida, and are suspected to be 
regulated similarly in P. aeruginosa (89).  Tryptophan also post-translationally inhibits 
the P. aeruginosa TrpE via competitive feedback inhibition by binding in a hydrophobic 
pocket and inhibiting the catalytic residues from interacting with chorismate (100, 116).  
It is unlikely that TrpEG is providing anthranilate for PQS biosynthesis.  This was shown 
when the additional two pathways that produce anthranilate were not functional, TrpEG 
was unable to supplement PQS production (37).  Furthermore, the tryptophan operons 
are down regulated when P. aeruginosa is grown in CF sputum, suggesting that TrpEG 
would not be responsible for supplying anthranilate for PQS production in vivo (91).  
With all of the presented data, it is unlikely that TrpEG is the source of anthranilate for 
the synthesis of PQS.  
 During the early investigation for the source of anthranilate used for the production 
of PQS, phnAB became the main focus due to the two gene operon clustering within the 
PQS synthetic locus (35, 41).  Also, previous studies have shown that phnA is positively 
regulated by the transcriptional regulator PqsR, which positively regulates the PQS 
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operon pqsABCDE, and further suggested that it would have a major role in the 
production of anthranilate for PQS biosynthesis (13).  However, results shown by 
Farrow and Pesci suggested otherwise (37).  The PQS extractions performed on the 
kynurenine pathway mutants in complex media revealed that PhnAB could not supply 
anthranilate for PQS production in kynurenine pathway mutants (Figure 1.5A) (37).  To 
further understand these results Farrow et al. investigated the source of anthranilate for 
PQS production during growth in a defined medium in the presence or absence of 
tryptophan (37).  In a defined minimal media with no tryptophan, the kynA mutant 
produced PQS and suggested that PhnA provided anthranilate for PQS production 
under these growth conditions (Figure 1.5C, lanes 4-6) (37).  This was confirmed when 
the phnA mutant did not produce PQS in the defined media and a phnAB 
complementing plasmid restored PQS production in the absence of tryptophan (Figure 
1.5C, lane 11) (37).  These results showed that PhnA is necessary for PQS production 
under nutrient limiting conditions and is negatively controlled during growth in rich 
media.  
 The regulation of phnAB is quite complex and it is expected to be regulated at both 
the transcriptional and translational level.  Analyses by RNA slotblot, microarray, and 
transcriptional fusions show that phnA expression peaks during stationary phase (13, 
16, 35).  At the transcriptional level, phnAB has been shown to be positively influenced 
by LasR, and negatively influenced by both RhlR and the orphan quorum sensing 
regulator QscR, though this influence could be through PqsR as it is regulated similarly 
(16, 88).  As stated previously PqsR has been shown to regulate phnAB (30, 31).  A 
purified recombinant PqsR protein was demonstrated to have a direct interaction with 
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phnAB, however the direct interaction was not shown in DNA binding assays with 
purified native, full-length PqsR performed by our lab (unpublished data) (13).  As for 
post-translational regulation, enzyme assays by Essar et al. suggested that PhnA is not 
inhibited in the presence of tryptophan (35).  Sequence alignment with the known 
tryptophan binding residues of anthranilate synthases revealed that PhnA only has one 
of the three residues known to interact with tryptophan and may explain the lack of post 
translational inhibition by this molecule (109).  To further complicate the regulation of 
phnAB, a P. aeruginosa trpE mutant (tryptophan auxotroph) was able to grow on 
tryptophan deplete media with a mutation frequency of 10-5 to 10-6 (35). The source of 
this mutation was not determined, but transcript levels of phnAB in the revertants are at 
high levels during all growth phases, which contrasts significantly with the stationary 
phase expression seen in the wild-type strain (16, 35).  This suggests that PhnAB can 
supply the anthranilate used for tryptophan synthesis, and that the mutation caused 
dysregulation of phnAB to allow for P. aeruginosa survival.  This mutation also resulted 
in a twenty percent increase in pyocyanin, which is a PQS controlled virulence factor 
(35).  Experiments that investigate the dysregulation of phnAB transcription by this 
unknown mutation are further explained in chapter three.  Overall, the regulation of the 
secondary anthranilate synthase phnAB appears to be complex, and elucidating this 
regulation should help us to better understand the source of anthranilate for PQS 
production. 
 
 CHAPTER TWO: KYNR, A LRP/ASN-C-TYPE TRANSCRIPTIONAL REGULATOR, 
DIRECTLY CONTROLS THE KYNURENINE PATHWAY IN PSEUDOMONAS 
AERUGINOSA  
2.1 Summary 
The opportunistic pathogen Pseudomonas aeruginosa can utilize a variety of 
carbon sources and produces many secondary metabolites to help survive harsh 
environments.  P. aeruginosa is part of a small group of bacteria that use the 
kynurenine pathway to catabolize tryptophan.  Through the kynurenine pathway, 
tryptophan is broken down into anthranilate, which is further degraded into tricarboxylic 
acid cycle intermediates or utilized to make numerous aromatic compounds, including 
the Pseudomonas quinolone signal (PQS).  We have previously shown that the 
kynurenine pathway is a critical source of anthranilate for PQS synthesis and that the 
kynurenine pathway genes (kynA and kynBU) were upregulated in the presence of 
kynurenine.  A putative Lrp/AsnC-type transcriptional regulator (gene PA2082, hereafter 
called kynR), is divergently transcribed from the kynBU operon and is highly conserved 
in Gram-negative bacteria that harbor the kynurenine pathway.  We show that a 
mutation in kynR renders P. aeruginosa unable to utilize L-tryptophan as a sole carbon 
source and decreases PQS production.  In addition, we found that the increase of kynA 
and kynB transcriptional activity in response to kynurenine was completely abolished in 
a kynR mutant, further indicating that KynR mediates the kynurenine-dependent 
expression of the kynurenine pathway genes.  Finally, we found that purified KynR 
specifically bound the kynA promoter in the presence of kynurenine, and the kynB 
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promoter in the absence or presence of kynurenine.  Taken together, our data show that 
KynR directly regulates the kynurenine pathway genes 
2.2 Introduction 
 Pseudomonas aeruginosa is a Gram-negative bacillus that is ubiquitous 
throughout nature and infects a variety of hosts.  It is a common nosocomial pathogen 
known to cause serious opportunistic infections in immunocompromised individuals 
(72).   P. aeruginosa also causes a chronic infection in cystic fibrosis (CF) patients that 
is difficult, if not impossible, to eradicate and ultimately leads to increased morbidity and 
mortality in this population (10, 112).  In order to survive during such infections and in 
many other harsh environments, P. aeruginosa can utilize numerous different carbon 
sources and produces a wide-range of secondary metabolites (57, 67, 79, 102, 114).  
One potential nutrient, tryptophan, can be used by some bacteria to provide building 
blocks for many secondary metabolites, some of which function as siderophores, 
signaling molecules, and protective compounds (2, 37, 79, 123).  Similar to eukaryotes, 
P. aeruginosa catabolizes tryptophan through the kynurenine pathway (37, 61).  
Kurnasov et al. utilized comparative genetics to identify several bacteria with putative 
kynurenine pathways, including Bacillus anthracis, P. aeruginosa, and Bordetella 
pertussis (61).  The kynurenine pathway contrasts significantly from the major 
tryptophan catabolic pathway of Escherichia coli (and many other species of bacteria), 
which catabolizes L-tryptophan anaerobically into indole, pyruvate, and ammonia via a 
pyridoxal phosphate-dependent tryptophanase (119, 134).  Nevertheless, with either 
catabolic pathway the ability to utilize both tryptophan and tryptophan-breakdown 
products as a carbon and nitrogen source, and as precursors for many secondary 
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metabolites, provides a unique advantage for survival within nutrient-limited and harsh 
environments.  
The conversion of L-tryptophan into quinolinate via the kynurenine pathway has 
been demonstrated in multiple bacterial species (61).  However, P. aeruginosa only 
encodes the genes for the anthranilate branch of the kynurenine pathway (62).  This 
branch catabolizes L-tryptophan into anthranilate via a three-step enzymatic pathway 
(61).  The three enzymes are encoded by kynA (which encodes a tryptophan-2,3-
dioxygenase), kynB (kynurenine formamidase), and kynU (kynureninase) (see Fig. 2.7 
for pathway) (37, 62).  The kynA gene is located separately on the P. aeruginosa 
chromosome, while kynB and kynU are encoded in a putative operon.  The kynurenine 
pathway was linked to P. aeruginosa virulence when it was shown that radiolabeled 
tryptophan was incorporated into the Pseudomonas quinolone signal (PQS) (37), which 
is important for virulence in multiple models of infection (29, 40, 76, 101, 130).  These 
data also showed that despite the presence of two alternative pathways for anthranilate 
production, the kynurenine pathway is the main source of anthranilate for PQS 
production when P. aeruginosa is grown in the presence of tryptophan or tryptophan 
breakdown metabolites (37, 91).   
Due to both the importance of the kynurenine pathway in the production of PQS 
and because tryptophan is a costly amino acid to synthesize (37, 137), it would be 
advantageous for P. aeruginosa to strictly regulate the catabolism of tryptophan.   
Multiple transcriptome arrays have shown that quorum sensing may regulate the 
kynurenine pathway (107, 122), and the quorum-sensing regulator LasR was predicted 
through ChIP-chip analysis to bind to the promoter region of kynB (43).  Our laboratory 
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has also shown that the transcription of both kynA and kynB was significantly increased 
in the presence of kynurenine (37).  With these data in mind, we began to search for a 
transcriptional regulator that could specifically regulate kynA and kynB in the presence 
of kynurenine.  We identified a putative transcriptional regulator encoded by gene 
PA2082, which is divergently transcribed from kynB and is homologous to the Lrp/AsnC 
family of transcriptional regulators.  Lrp/AsnC-type regulators are known to control 
amino acid metabolism, and though Lrp has a global regulatory role in E. coli, many 
other regulators within the family have more specific regulons (8, 135).  We 
demonstrate here that the protein encoded by gene PA2082 directly binds to and 
regulates the kynurenine pathway genes, and therefore propose that this protein be 
named the kynurenine pathway regulator (KynR). 
2.3 Material and Methods 
2.3.1 Bacterial strains, plasmids, and culture conditions 
E. coli and P. aeruginosa strains were respectively maintained in 30% glycerol 
and 10% skim milk (Difco) at -80°C, and were freshly plated to begin each experiment. 
All strains and plasmids used are listed in Table 2.1.  Bacteria were cultured at 37°C in 
Luria Bertani medium (LB), Vogel Bonner minimal media supplemented with 0.5% 
glycerol (VBG) (120), or Sole Carbon Source Media (SCM) containing 73.4 mM 
K2HPO4, 16.76 mM NaNH5PO4.4H2O, 0.8 mM MgSO4; and with either 10 mM L-
tryptophan (TSCM) or 10 mM L-alanine (ASCM) (pH 7.0).  Cultures were supplemented 
with the kynurenine pathway metabolites as indicated below.  Growth was monitored 
spectrophotometrically by optical density at 600 nm (OD600) for E. coli or OD660 for P. 
aeruginosa.  To maintain plasmids, 30 µg/ml chloramphenicol, 100 µg/ml ampicillin, 200  
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Table 2.1. List of strains and plasmids used in this study. 
Strain or Plasmid Relevant genotype or phenotype  Reference  
 
    E. coli DH5α 
 
 
 
    P. aeruginosa strains 
        PAO1 
        PAO-R1        
        PJF-KA1 
        PJF-KB1 
        PJF-KU1 
        PAΔKynR 
        PAO-R1DKynR 
 
Plasmid 
    pHERD30T 
    pKynRex 
    pACYC184 
    pKynRsubex 
 
    pEX18Ap 
    pkynRdel 
    pLP170 
    pJF01 
    pJF03 
 
 
F’/endA1, hsdR17, supE44 thi-1, recA1, gyrA, 
relA1, (lacZYA-argF) U169, deoR 
[Φ80dlacΔ(lacZ)M15recA1] 
 
 
Wild-type 
lasR::Tc deletion mutant derived from strain PAO1 
kynA deletion mutant derived from strain PAO1 
kynB deletion mutant derived from strain PAO1 
kynU deletion mutant derived from strain PAO1 
kynR deletion mutant derived from strain PAO1 
kynR, lasR deletion mutant derived from strain 
PAO-R1 
 
PBAD- based shuttle vector, Gmr 
KynR expression vector, Gmr 
General purpose cloning vector, Tetr and Chlr 
KynR expression vector derived from pKynRex, 
Chlr 
Suicide vector, Ampr 
kynR deletion suicide vector, Ampr 
lacZ transcriptional fusion vector, Ampr 
kynB’-lacZ transcriptional fusion, Ampr 
kynA’-lacZ transcriptional fusion, Ampr 
 
 
(129) 
 
 
 
 
(53) 
(42) 
(37) 
(37) 
(37) 
This study 
This study 
 
 
(99) 
This study 
(14) 
This study 
 
(51) 
This study 
(98) 
(37) 
(37) 
Abbreviations: Gmr, gentamicin resistance; Tetr, tetracycline; Chlr, chloramphenicol; and Ampr, 
ampicillin 
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µg/ml carbenicillin, or 15 µg/ml (E. coli) or 30 µg/ml (P. aeruginosa) gentamicin was 
added when appropriate.  
In order to generate an expression plasmid for KynR, a 568 bp DNA fragment, 
which began at the kynR start codon (ATG) and ended 46 bp downstream from the stop 
codon was amplified by PCR using strain PAO1 chromosomal DNA as the template.  
The oligonucleotide primers used for this amplification were engineered to contain a 
single HindIII site downstream from the stop codon (Table 2.2).  Vector plasmid 
pHERD30T, which contains an araBAD (PBAD) promoter to control gene expression, 
was digested sequentially with SmaI and HindIII.  The digested plasmid DNA was 
ligated with the kynR PCR fragment, which had also been digested with HindIII, to 
create the plasmid pKynRex.  This plasmid was used to amplify kynR and regulatory 
elements for use in a two-plasmid system in E. coli.  PCR was used to amplify both the 
kynR and divergently transcribed araC to ensure all elements necessary for controlled 
expression of KynR were included in the subcloned plasmid.  Primers were located 52 
bp downstream from araC and 46 bp downstream from kynR.  The resulting PCR 
fragment, as well as pACYC184, were sequentially digested with SalI and HindIII and 
ligated together, generating plasmid pKynRsubex.  
2.3.2 Generation of kynR mutants 
A splicing by overlap extension protocol was used to generate mutant alleles 
(126).  Alleles were constructed to contain in-frame deletions in the coding DNA 
sequences corresponding to amino acids 25 to 140 for kynR (73% of protein sequence).  
Primers were designed to contain approximately 1 kb of DNA both upstream and 
downstream from the splice junction and each primer added an EcoRI restriction site to  
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Table 2.2.  List of primers used in this study.  
Primer Name Sequence (5’ to 3’)a 
 
Primers for Mutagenesis 
    2082-F1-remake 
    PA2082Rev1 
    PA2082Fwd2 
    PA2082Rev2 
   
Primers for KynR 
expression 
    2082atgfwd 
    2082 Rev Herd 
    Herd2082exsubRev 
 
EMSA 
    kynApromoterfwd 
    kynApromoterrev 
    kynBpromoterfwd 
    kynBpromoterrev 
    FwdKynU-EMSA 
    RevKynU-EMSA 
 
 
 
AAAAAAGAATTCGAGGTAGATCACGCCGTC 
CCGGCCTTGATCTCCTGCAGTCCTGGTTGCTCATCCGCCC 
GGGCGGATGAGCAACCAGGACTGCAGGAGATCAAGGCCGG 
AAAAAAGAATTCGAACTTGGCGGCGATGG 
 
 
 
ATGTCCCTGGACGCCATCGA 
AAAAAAGCTTCGTCCCTCTCATTGCACT 
AAAAGTCGACCGAAGCAGGGTTATGCAGC 
 
 
GAGTGAGGGCAAGGACACAT 
CGCGAGTGATCCGAAATTCG 
GACTGATGTCCCAGTAGCGG 
GACGGAGAATGCGCAGATCG 
GGTACTTGTAGGTGCAGCCG 
CAAGACCGGCTACCTGCACG 
 
aRestriction sites indicated by bold type. 
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both ends of the PCR product.  Both the kynRdel-PCR product and pEX18Ap (suicide 
vector) were digested with EcoRI and ligated together.  The resulting plasmid, 
pkynRdel, was transformed into strains PAO1 and PAO-R1 by electroporation (15).  
Mutants were selected for by plating transformants on medium containing carbenicillin 
and then on medium containing 6% sucrose to remove the vector sequence (51).  PCR 
was used to screen colonies and DNA sequencing of PCR products was used to 
confirm mutants. 
2.3.3 PQS production 
Washed cells from overnight cultures were used to inoculate 10 ml cultures of LB 
or VBG supplemented either with water, 1 mM L-tryptophan, 1 mM L-kynurenine, or 1 
mM anthranilate (final concentrations) to an OD660 of 0.05.  After 6 and 24 h of growth, 
300 µl samples of each culture were extracted with 900 µl of acidified ethyl acetate as 
previously described (20).  One-half of the resulting organic phase was evaporated to 
dryness at 37°C and 50 µl of 1:1 acidified ethyl acetate:acetonitrile was used to 
reconstitute the extract.  Samples were analyzed by thin-layer chromatography, 
visualized by long-wave UV light, and photographed (20).   
2.3.4 β-galactosidase (β-gal) assays in P. aeruginosa 
 Cells from overnight cultures of P. aeruginosa grown in VBG were washed and 
resuspended in fresh medium to an OD660 of 0.05 and incubated at 37°C with shaking at 
≥180 rpm for 6 h.  At that time either water or 1 mM L-kynurenine was added and 
cultures continued to grow at 37°C with shaking at ≥180 rpm for an additional 18 h.  The 
cells were collected by centrifugation at 12,000 x g for 2 min, resuspended in fresh 
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VBG, and assayed for β-gal activity in duplicate.  Data are presented in Miller units as 
the mean ± the standard deviation (σn-1) of at least 3 separate experiments. 
2.3.5 β-gal assays in E. coli.  
Overnight cultures of E. coli carrying the appropriate plasmids were grown in LB 
and used to inoculate 10 ml cultures of fresh media to an OD600 of 0.08.  The 
subcultures were incubated at 37°C with shaking at ≥180 rpm until an OD600 of 0.3 was 
reached.  Then 2 ml aliquots were transferred to tubes that contained 0.1% L-arabinose 
to induce kynR expression and either water, 1 mM L-kynurenine, 1 mM L-tryptophan, or 
1 mM anthranilic acid (final concentrations) was added.  The cells were incubated for 2 
h at 37°C with shaking at ≥180 rpm.  After incubation, the β-gal activity produced by 
each culture was assayed and data are reported as the mean ± the standard deviation 
(σn-1) of at least 3 independent experiments. 
2.3.6 Purification of KynR  
The method used for purification of KynR is a modification of those described by 
Madhusudhan et al. for the purification of BkdR from Pseudomonas putida (75).  A 10 
ml overnight culture of E. coli strain DH5α (pKynRex) was used to inoculate 250 ml of 
LB and was incubated at 37°C with shaking at ≥ 180 rpm until an OD600 of 0.7 was 
reached.  At this point, 1% L-arabinose (Sigma-Aldrich) was added to induce kynR 
expression and the culture was grown for an additional 3 h at 37°C with shaking at ≥ 
180 rpm.  Cells were harvested by centrifugation at 6,000 x g for 10 minutes and then 
resuspended in 20 mM Tris-HCL pH 7.4 and 1 mM dithiothreitol (DTT) (buffer A).  The 
cells were lysed by sonication and the lysate was cleared by centrifugation at 37,000 x g 
for 1 h at 4°C (Beckman Coulter Optima L-100 XP Ultracentrifuge).  KynR purification 
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was performed at room temperature and all samples were kept on ice or at 4°C until 
purification was complete.  The soluble fraction (90 mg total protein) was applied to a 
HiTrap DEAE Sepharose Fast Flow column (1 ml, GE Healthcare) in buffer A at a flow 
rate of 0.5 ml/min.  The column was washed with buffer A until the A280 returned to 0 
(~50 ml).  Bound proteins were eluted with a 30 ml linear gradient of 0 to 0.3 M NaCl at 
a flow rate of 1 ml/min, and 3 ml fractions were collected.  Samples from the collected 
fractions were precipitated using deoxycholic acid and tricholoracetate acid (DCA/TCA) 
and then separated by 15% SDS-PAGE to identify fractions containing KynR.  These 
fractions were collected and dialyzed against a buffer containing 20 mM Tris-HCL pH 
7.4, 100 mM NaCl, 5 mM MgCl2, and 1 mM DTT (buffer B) overnight at 4°C.  The 
dialyzed fractions were then applied to a HiTrap Heparin (5 ml, GE Healthcare) column 
equilibrated with buffer B.  The column was washed with buffer B until the A280 returned 
to 0 (~24 ml).  Bound proteins were eluted with a 50 ml linear gradient of 0.1 to 0.4 M 
NaCl in buffer B at a flow rate of 1 ml/min and 3 ml fractions were collected.  Again, 
proteins from the collected fractions were precipitated with DCA/TCA and were 
separated on a 15% SDS-polyacrylamide gel to identify the fractions containing KynR.  
All fractions containing KynR were pooled and dialyzed against 20 mM Tris-HCL pH 7.8 
and 1 mM DTT (buffer C) overnight at 4°C.  The dialyzed fraction was then added to a 
HiTrap DEAE Sepharose Fast Flow column (1 ml, GE Healthcare) equilibrated with 
buffer C.  The column was washed with buffer C until the A280 returned to 0 (~12 ml) and 
bound proteins were eluted with a 30 ml linear gradient of 0 to 0.3 M NaCl at a flow rate 
of 1 ml/min and 3 ml fractions were collected.  Samples from collected fractions were 
precipitated with DCA/TCA and separated on a 15% SDS-PAGE to identify the fractions 
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that contained KynR.  The fractions containing KynR resulted in 95% purity of KynR as 
judged by SDS-PAGE (data not shown).  Glycerol was added to the pooled KynR 
fractions to a final concentration of 15% and the protein was stored at -80°C. 
Column fractions during purification were monitored by absorbance  
measurements at 280 and 260 nm with a NanoDrop ND-1000 spectrophotometer.   
After purification, the final protein concentration was 4.34 mg/ml (244 mol) of protein, as 
determined by a Bradford assay using BioRad reagents.  In addition, protein 
concentrations for electrophoretic mobility shift assays (EMSA) were determined by the 
Bradford assay using Bio-Rad reagents.  
2.3.7 EMSA 
PCR was used to generate DNA fragments containing the kynA (228 bp, +208 bp 
to -20 bp relative to ATG) and kynB (200 bp, +169 bp to -31 bp relative to the ATG) 
promoter regions.  An internal fragment of kynU (157 bp, +527 bp to +685 bp relative to 
the ATG) was also generated by PCR as a negative control.  DNA fragments were 
labeled with [γ-P32] ATP (Perkin-Elmer, Wellesley, MA) by using T4 polynucleotide 
kinase (Invitrogen, Carlsbad, CA).  The binding assays were carried out in buffer 
containing 20 mM Tris-HCl (pH 7.4), 50 mM NaCl2, 5 mM MgCl2, 1 mM dithiothreitol, 
and 10% glycerol.  Each reaction mixture contained 0.3 µg of salmon sperm DNA, 
approximately 1.5 x 104 cpm radiolabeled DNA, and 0 to 488 pmol of protein.  Binding 
reactions were performed in both the presence and absence of 0.1 mM L-kynurenine or 
0.1 mM L-tryptophan.  Reactions mixtures were incubated at room temperature for 20 
min and separated by electrophoresis at 4°C on a native 10% polyacrylamide gel [29:1 
acrylamide to bis-acrylamide, 1X Tris-borate buffer (89 mM Tris and 89 mM Borate, pH 
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8.0), and 2.5% glycerol] for 5 minutes at 200 V and then 4 hours at 100 V.  After 
electrophoresis, the gels were dried and visualized by autoradiography. 
2.4 Results 
2.4.1 The identification of a putative regulator of the kynurenine pathway  
To begin our search for potential regulators of the kynurenine pathway, we first 
analyzed the predicted function of annotated genes located near the kynurenine 
pathway operons in P. aeruginosa (www.pseudomonas.com).  The kynurenine pathway 
genes are located separately on the P. aeruginosa chromosome, with kynB and kynU 
located in a putative polycistronic operon and kynA located on a distant putative 
monocistronic operon (Figure 2.1A).  A potential transcriptional regulator encoded by 
gene PA2082, was divergently transcribed from kynB in P. aeruginosa and appeared to 
be a member of the Lrp/AsnC family of transcriptional regulators (Figure. 2.1B).  These 
regulators are known to be important for controlling amino acid metabolism and are 
often encoded adjacent to pathway genes that they regulate (8).  We used a 
comparative genomics approach and began to examine other bacteria that harbor the 
kynurenine pathway genes to determine if they also possessed similar regulator 
proteins.  Both the Burkholderiacea and Pseudomonadaceae families encoded a 
PA2082 homolog divergently oriented from either kynB or kynU in the Burkholderia, 
Ralstonia, Cupavarius, Bordetella, and Pseudomonas genera (Fig. 2.1B).  P. 
aeruginosa only contains the anthranilate branch of the kynurenine pathway, while 
some of the Burkholderia species and P. fluorescens apparently contain the pathway to 
catabolize tryptophan into quinolinate or the siderophore quinolobactin (61, 79).  Also,  
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Figure 2.1. The kynR gene is conserved in other Gram-negative bacteria that have the 
kynurenine pathway genes. A.  The two loci of the kynurenine pathway genes in P. 
aeruginosa.  B. A schematic to show the conservation of kynR.   The shading on each 
gene corresponds to the homologous genes in part A.  * Indicates that kynB and kynA 
are located separately on the chromosome in a putative operon.  
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Bacillus cereus and Bacillus anthracis contain the kynurenine pathway genes (62), but 
these species have a TetR-like regulator divergently oriented from kynU that may be 
responsible for an alternative regulatory scheme.  Overall, these findings suggested that 
the putative transcriptional regulator encoded by PA2082, which we hereby designate 
as KynR (kynurenine pathway regulator), might play a role in regulating tryptophan 
catabolism in P. aeruginosa.  
In order to examine the role of KynR in tryptophan catabolism we assessed the 
impact of KynR on kynurenine pathway-dependent phenotypes.  The kynurenine 
pathway is the only enzymatic pathway identified in P. aeruginosa capable of degrading 
tryptophan (61).  To confirm this, we grew mutants containing deletions of the 
kynurenine pathway genes kynA (PJF-KA1), kynB (PJF-KB1), and kynU (PJF-KU1) in a 
minimal salts media with tryptophan as the only carbon source (TSCM) (Figure 2.2A).  
The wild-type strain PAO1 utilized tryptophan as a sole carbon source and grew to an 
OD660 of over 0.5 (Figure 2.2A).  However, the kynurenine pathway mutants were 
unable to grow with only tryptophan as a carbon source (Figure 2.2A).  As a control, the 
strains were also grown on alanine as a sole carbon source (ASCM) and the kynurenine 
pathways mutants were able to grow to wild-type levels (data not shown).  These results 
confirmed that the kynurenine pathway is required for tryptophan catabolism in P. 
aeruginosa.  Next, we tested whether the kynR mutant strain PAΔKynR was able to 
grow on tryptophan as a sole carbon source (Figure 2.2B).  The results indicated that, 
like the kynurenine pathway mutants, PAΔKynR was unable to grow on tryptophan 
alone.  In order to determine if the inhibition of growth was due to the loss of kynR,  
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Figure 2.2. Utilization of L-tryptophan as a sole carbon source.  A. Bacterial strains 
PAO1 (circles), PJF-KA1 (X), PJF-KB1 (diamonds), PJF-KU1 (asterisks) were grown in 
TSCM and OD660 was measured.  B.  Bacterial strains PAO1 (open circles), PAO1 + 
0.1% arabinose (open squares), PAO1(pKynRex) + 0.1% arabinose (open triangles), 
PAΔKynR (closed circles), PAΔKynR + 0.1% arabinose (closed squares), and 
PAΔKynR(pKynRex) + 0.1% arabinose (closed triangles) were grown in TSCM and 
OD660 was measured.  Values depict the mean ± σn-1 from at least three separate 
experiments. 
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strains PAΔKynR and PAO1 were transformed with a plasmid harboring wild-type kynR 
under an arabinose inducible promoter (pKynRex).  Expression of KynR in strain 
PAΔKynR caused growth on tryptophan to be similar to that of the parent strain PAO1 
(Figure 2.2B).  Since P. aeruginosa can utilize arabinose as a carbon source, we also 
included control cultures to ensure that the arabinose that was added for KynR 
expression was not affecting the growth phenotypes and observed that the effect was 
negligible (Figure 2.B).  Overall, these data indicated that a kynR mutant was unable to 
grow on tryptophan as a sole carbon source, and further supported the notion that KynR 
has a role in the regulation of the kynurenine pathway. 
2.4.2 PQS production is affected in a kynR mutant.   
Previous studies showed that the kynurenine pathway mutants produced little to 
no detectable PQS and suggested that the kynurenine pathway is the main source of 
anthranilate for PQS production when tryptophan or its breakdown metabolites are 
present (37).  Therefore, we were interested in testing whether a mutation in kynR 
would also have an effect on PQS production.  Strains PAO1 and PAΔKynR were 
grown in LB and VBG supplemented with tryptophan, kynurenine, anthranilic acid, or 
water (as a control).  The cultures were grown for either 6 or 24 h and then were 
extracted with acidified ethyl acetate.  The extracts were analyzed by TLC to assay both 
PQS and anthranilate production.  After 6 and 24 h of growth in LB or LB supplemented 
with tryptophan, strain PAΔKynR produced less PQS (Figure 2.3A and 3B, lanes 6 and 
7) than the wild-type strain PAO1 (Figure 2.3A and B, lanes 2 and 3).  This suggested 
that kynR affects the supply of anthranilate for PQS production by positively controlling 
an element of the kynurenine pathway.   
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Figure 2.3: The production of anthranilate and PQS is decreased in the kynR mutant.  
Ethyl acetate extracts from cultures grown for 6 (A) and 24 h (B) were analyzed by TLC. 
Equal volumes of extracts were resolved in each lane, and the addition of water (W), 1 
mM L-tryptophan (T), 1 mM L-kynurenine (K), or 1 mM anthranilic acid (A) to the 
respective culture is indicated at the top of each lane.  Lane 1 contains 75 ng of PQS 
and lane 18 contains 1.25 ng of anthranilic acid as controls.  Lanes 2 to 5 contain 
extracts from strain PAO1 grown in LB; lanes 6-9 contain extracts from strain PAΔKynR 
grown in LB; lanes 10-13 contain extracts from strain PAO1 grown in VBG; and lanes 
14-17 contain extracts from strain PAΔKynR grown in VBG. 
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We then saw something unexpected when the addition of kynurenine to LB 
resulted in wild-type amounts of PQS being produced by strain PAΔKynR after both 6  
and 24 h (Figure 2.3A and B, lane 8).  This suggested that KynR was not the only factor 
that controls kynBU, which must be induced for the conversion of kynurenine to 
anthranilate to be used for PQS synthesis (see Figure 2.7 for pathway).  PQS was also 
extracted from both strains grown in a minimal media to assess the effects of 
supplementing with individual kynurenine pathway metabolites.  The production of PQS 
by strains PAO1 and PAΔKynR grown in VBG differed somewhat from those in LB, but 
followed a similar trend.  PQS was not detectable from either strain after 6 h of growth in 
VBG, but the addition of tryptophan or kynurenine to the media induced the production 
of anthranilate by the wild-type strain PAO1 (Figure 2.3A, lanes 11 and 12).  Unlike the 
wild-type strain PAO1, strain PAΔKynR only produced anthranilate with the addition of 
kynurenine and not when tryptophan was added (Figure 2.3A, lanes 15 and 16).  After 
24 h of growth in VBG, PQS was detectable from both strains under all conditions and 
anthranilate was no longer detectable after presumably being used by the cells (Figure 
2.3B, lanes 10-17).  Taken together, the data suggested that KynR indirectly regulates 
PQS production, presumably through the kynurenine pathway, but that it is not 
absolutely required for PQS to be produced. 
2.4.3 KynR is required for kynurenine dependent induction of kynurenine pathway 
genes.   
Thus far the phenotypes of the kynR mutant have implied that KynR plays a role 
in the kynurenine pathway.  In addition, our previous work had shown that the 
transcription of both kynA and kynB were induced in the presence of kynurenine (37).  
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Therefore, we decided to determine if KynR affected the expression of kynA and kynB 
in a defined medium (VBG) where we could control the concentration of kynurenine.  To 
study this, we performed β-gal assays in strains PAO1 and PAΔKynR harboring the 
respective kynA’-lacZ and kynB’-lacZ transcriptional fusion plasmids pJF03 and pJF01.  
Our data showed that after 24 h of growth in VBG media in the absence of kynurenine, 
the expression of both kynA and kynB were similar in both the parental and kynR 
mutant strains (Figure 2.4A and B).  However, the addition of 1 mM kynurenine resulted 
in a large induction of both kynA and kynB in the wild-type strain PAO1, but this 
induction did not occur in the kynR mutant (Figure 2.4A and B).  These data led us to 
conclude that in the presence of kynurenine, KynR is positively regulating kynA and 
kynB transcription.    
It has been suggested from microarray experiments that kynB is directly 
regulated by the quorum sensing regulator LasR (43).  Since our data in Figure 2.3 also 
suggested that a factor in addition to KynR was regulating kynBU, it seemed logical that 
we should examine whether LasR affected kynBU transcription.  The data of Figure 
2.4B showed that kynB transcription was greatly decreased in a lasR mutant when 
kynurenine is not present but that the addition of kynurenine will override the lasR 
mutation.  In addition, a lasR, kynR double mutant exhibited no transcription of kynB in 
the presence or absence of kynurenine (Figure 2.4B).  Taken together, the data of 
Figure 2.4 lead us to conclude that kynBU is controlled by LasR when kynurenine is 
absent and by KynR when kynurenine is available.    
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Figure 2.4: The kynurenine pathway genes are not induced by kynurenine in a kynR 
mutant.  β-gal activity of (A) kynA’-lacZ fusion (pJF03) and (B) kynB’-lacZ fusion (pJF01) 
in strains PAO1 (solid bars), PAΔKynR (striped bars), PAO-R1 (open bars), and PAO-
R1ΔKynR (stippled bars) were assayed in cultures grown in VBG or 6 h and then 
supplemented with either water (as a control) or 1 mM L-kynurenine for 18 h.  β-gal 
activity is presented in Miller units as the mean ± σn-1 of results from duplicate assays 
from at least three separate experiments.   
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Figure 2.5: KynR can induce expression of kynB’-lacZ in the presence of L-kynurenine 
in E. coli.  E. coli strain DH5α (pJF01)(pKynRex) was grown in LB media in the 
presence of water as a control water (white bar), 1 mM L-kynurenine (Kyn, black bar), 1 
mM L-tryptophan (Trp, striped bar), or 1 mM anthranilate (AA, grey bar).  After 3 h of 
growth the cultures were induced with 0.1% arabinose and grown for an additional 3 h.  
The cultures were then assayed for β-gal activity, which is presented in Miller units as 
the mean ± σn-1 of results from at least three experiments. 
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2.4.4 KynR directly regulates the kynurenine pathway.   
Our data have shown so far that KynR is required for the kynurenine-dependent 
increase of both kynA and kynB transcription (Figure 2.4A and B), but whether this 
regulation was direct or indirect was unknown.  To eliminate any possibility of 
endogenous P. aeruginosa factors altering the results of our kynA and kynB  
transcriptional fusion assays, we utilized an E. coli two-plasmid system to try to 
establish a more direct link between KynR and the induction of kynA and kynB.  [Note: It 
is important to point out here that E. coli does not contain the genes for the kynurenine 
pathway.]  E. coli strain DH5α harboring either a kynA’-lacZ (pJF03) or a kynB’-lacZ 
(pJF01) transcriptional fusion and the KynR overexpression plasmid (pKynRsubex) was 
grown in LB in the presence of tryptophan, kynurenine, or anthranilate, and the 
expression of KynR was induced with the addition of 0.1% arabinose.  The results 
presented in Figure 2.5 showed that the expression of kynB’-lacZ was only induced in 
the presence of KynR and kynurenine, and not when tryptophan or anthranilate was 
present.  Unfortunately, the similar assays performed with the kynA’-lacZ fusion showed 
that it was constitutively active in E. coli and direct regulation by KynR could not be 
demonstrated in this experiment (data not shown).  Nevertheless, the results of Figure 
2.5 suggested that KynR can directly activate the expression of kynB, and that 
kynurenine acts as a coinducer for KynR.   
To determine if KynR directly binds to the kynA and kynB promoter regions in 
response to kynurenine, we purified KynR and performed electrophoretic mobility shift 
assays (EMSA).  KynR was purified from E. coli strain DH5α (pKynRex) and incubated 
with either the kynA or kynB promoter region in the presence or absence of kynurenine.  
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Figure 2.6: KynR binds to the kynA and kynB promoter regions.  A.  KynR was added 
to [γ-P32]kynA in both the presence and absence of 10 µM kynurenine (kyn).  B.  KynR 
was added to [γ-P32]kynB in both the presence and absence of 10 µM kynurenine.  C.  
KynR was added to  [γ-P32]kynA and  [γ-P32]kynB in both the presence and absence of 
10 µM tryptophan (trp).  D.  KynR was added to  [γ-P32]kynU DNA fragment in both the 
presence and absence of 10 µM kynurenine.  The total amounts of KynR are indicated 
below each lane.  Total binding reaction mixtures were electrophoresed on 
nondenaturing 6% polyacrylamide gels.  Gels were dried, and overlaid X-ray film was 
exposed for 2 days before being developed. 
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We also added tryptophan in separate binding reactions to determine if it had an effect 
on the ability of KynR to bind DNA.  As a non-specific binding control, an internal kynU 
fragment was radiolabeled and utilized in binding reactions with KynR and kynurenine.  
The results of all EMSAs are shown in Figure 2.6.  These data indicated that KynR only 
bound to the kynA promoter in the presence of kynurenine (Figure 2.6A, right panel), 
and KynR is unable to bind kynA in the absence of a coinducer (Figure 2.6A, left panel).  
Additionally, tryptophan had no effect on the ability of KynR to bind to the kynA 
promoter (Figure 2.6C, left panel).  In contrast to kynA, the kynB promoter was bound 
by KynR in both the presence and absence of kynurenine (Figure 2.6B).  This binding 
was not affected by tryptophan (Figure 2.6C, right panel) and indicated that the kynA 
and kynB promoters are recognized by KynR in different manners.  It should also be 
noted that in the presence of kynurenine, an observable shift with kynB occurred with 
1.9 pmol of KynR (Figure 2.6B, right panel) while 7.62 pmol KynR was needed for a 
kynB shift to occur in the absence of kynurenine (Figure 2.6B, left panel).  This showed 
that KynR has a greater affinity for the kynB promoter in the presence of kynurenine.  
Furthermore, when compared to the interaction with kynA, the binding of KynR to kynB 
exhibited a more complex pattern of DNA migration retardation as the protein 
concentration increased.  These results suggest that the binding of KynR-kynurenine to 
the kynA promoter represented the binding of a single complex to the DNA, and that 
multiple KynR complexes, with or without a kynurenine coinducer, most likely interact 
with the kynB promoter.  Taken together, these data indicated that KynR bound to the 
kynA promoter in a kynurenine-dependent manner, while the interaction of KynR with 
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the kynB promoter occurred both in the presence and absence of kynurenine in a less 
constricted manner.  
2.5 DISCUSSION 
 We have previously shown that the transcription of both kynA and kynB was 
induced in the presence of kynurenine (37).  This led us to believe that a transcriptional 
regulator was responsible for the induction of the kynurenine pathway genes in the 
presence of kynurenine.  With this in mind, we identified KynR as the transcriptional 
regulator for the kynurenine pathway.  The kynR gene is divergently transcribed from 
kynB, and is found in the same genomic context in other Gram-negative bacteria with 
kynurenine pathway genes (Figure 2.1).  To begin to characterize the role of KynR on 
the expression of the kynurenine pathway genes, we first determined that P. aeruginosa 
required kynA, kynB, and kynU to grow on tryptophan as a sole carbon source (Figure 
2.2).  This phenotype provided a testable method to determine if KynR was important 
for expression of the kynurenine pathway.  When the kynR mutant was grown in TSCM, 
it was unable to utilize tryptophan as a sole carbon source, thereby indicating that KynR 
was involved in tryptophan degradation and leading us to explore its role as the 
regulator of the kynurenine pathway genes.  
Due to the similar phenotypes of the kynurenine pathway mutants and kynR 
mutants when grown on tryptophan as a sole carbon source, we felt that this regulator 
would probably affect PQS production.  We have previously shown that the kynurenine 
pathway is the main source of anthranilate for PQS production in rich media and that 
kynA and kynU mutants produce no detectable PQS, while kynB mutants produce trace 
amounts of PQS (37).  To our surprise, the data indicated that a mutation in kynR 
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caused only a partial decrease in PQS production (Figure 2.3).  This was probably due 
to the fact that we have mutated a pathway regulator as opposed to a structural gene 
(i.e. kynA, B, or U) that directly acts to breakdown tryptophan.  We also found that the 
addition of kynurenine to the kynR mutant resulted in a wild-type level of PQS 
production, which means that kynBU was at least partly induced in the absence of 
KynR.  This was explained by showing that kynB is positively regulated by LasR (Figure 
2.4), indicating that multiple regulators control this gene.  
To determine how KynR was effecting the kynurenine pathway genes, we 
analyzed the transcriptional activity of kynA and kynB in our kynR mutant.  Our data 
showed that both kynA and kynB were induced only in the presence of both KynR and 
kynurenine (Fig. 4), thereby implying that kynurenine was acting as a coinducer for 
KynR.  These studies were then taken a step further when we showed that KynR and 
kynurenine were required and sufficient for the activation of kynB in E. coli (Figure 2.5).  
This suggested that the regulation of kynB by KynR was direct, and made it clear that 
the regulation of the kynurenine pathway in P. aeruginosa differs from tryptophan 
degradation pathways in other bacteria where the expression of the pyridoxal 
phosphate-dependent tryptophanase is post-transcriptionally regulated through 
attenuation (134).  Taken together, the data we accumulated suggested that the 
kynurenine pathway is directly regulated in a positive way by KynR in a kynurenine-
dependent manner.  
To explore this potential direct regulation, we utilized purified KynR in DNA 
binding assays to study its interaction with the kynA and kynB promoters (Figure 2.6).  
These studies showed that KynR bound to the kynA promoter only in the presence of 
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kynurenine, and that it would bind to the kynB promoter in the presence or absence of 
kynurenine.  The addition of kynurenine did cause KynR to have a higher affinity for the 
kynB promoter, but the ability to bind kynB in the absence of kynurenine was interesting 
and not entirely unexpected.  Ligand independent binding by Lrp/AsnC-type regulators 
is typically observed when the regulator and target gene are divergently transcribed and 
adjacent to each other, as is the case with kynB and kynR (8).  Such genetic 
organization often results in decreased transcription of either the regulator or both the 
regulator and target gene (8), but we have not demonstrated this for kynB or kynR.   
Another interesting observation from the EMSA experiments was the differences 
that were observed between the binding complexes that KynR formed with the kynA 
and kynB promoter regions.  The kynA-KynR-kynurenine complexes migrated the same 
regardless of the KynR concentration, while the kynB-KynR complexes had different 
migration rates with increasing concentrations of KynR (with and without kynurenine 
present).  This type of migration pattern could be the result of KynR binding to multiple 
sites within the promoter region.  Multiple binding sites, as well as DNA bending, have 
been reported in several Lrp/AsnC-type regulators in E. coli and other bacteria (24, 39, 
54, 124, 125).  In addition, Lrp/AsnC type transcriptional regulators can bind as 
multimers both in the presence and absence of a ligand and are capable of acting as 
both activators and repressors (8, 135), so this seems to be the most likely explanation 
for the results seen with the kynB promoter binding assays.   
Overall, our findings show that tryptophan degradation in P. aeruginosa is 
upregulated by a positive feedback mechanism and suggests that the pathway would be 
activated in tryptophan-rich environments.  To help understand this, we have included a  
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Figure 2.7:  Proposed model for KynR regulation and the kynurenine biosynthetic 
pathway.  In this model tryptophan is degraded via three separate enzymes and made 
into anthranilate.  Anthranilate can either be used for the production of 4-quinolones 
such as PQS or is broken down into TCA cycle intermediates.  KynR interacts with 
kynurenine to become a transcriptional activator for both kynA and kynBU. 
 
 
 
     
kynA kynB kynR kynU PA2079 
 
Tryptophan 2,3-
dioxygenase 
Kynurenine  
formamidase 
Kynureninase 
PQS TCA cycle intermediates 
 KynR 
 
Kynurenine Anthranilate Tryptophan Formyl Kynurenine 
 KynR 
 
 
O
O
N
H
O O
 LasR 
 
+ 
+ 
+ 
 
53 
proposed model of tryptophan degradation by P. aeruginosa (Figure 2.7).  This model 
incorporates our previous results which showed that the kynurenine pathway is a major 
source of anthranilate for PQS production in the presence of tryptophan and tryptophan-
breakdown products (37).  Similarly, Chugani and Greenberg (17) demonstrated that 
the kynurenine pathway was necessary for the expression of catB, a gene encoding an 
enzyme involved in anthranilate catabolism.  These findings suggest that the kynurenine 
pathway could be active in amino-acid rich environments, such as in the CF lung (2, 90, 
115).  While one study found only 10 µM free tryptophan in CF sputum (90), it is well 
known that CF sputum also contains increased amounts of protein (3, 52, 87, 117).  P. 
aeruginosa is well-known to utilize proteases during infections within the CF lung (48, 
115) and these enzymes could readily liberate tryptophan from host or bacterial proteins 
found in sputum.  The ability of P. aeruginosa to catabolize tryptophan via the 
kynurenine pathway would provide a good source of both carbon for growth and 
anthranilate for the production of 4-quinolones (and many other secondary metabolites) 
during human infections (37).  Whether the kynurenine pathway is providing anthranilate 
for the production of PQS or for nutrient acquisition through anthranilate catabolism, this 
pathway provides a unique tool for P. aeruginosa to regulate virulence through PQS or 
survival through carbon and nitrogen source acquisition.
 CHAPTER THREE: A CONSERVED SILENT MUTATION IN A TRYPTOPHAN 
AUXTOTROPH RESULTS IN DYSREGULATION OF PSEUDOMONAS QUINOLONE 
SIGNAL SYNTHESIS 
3.1 Summary 
 Pseudomonas aeruginosa is a common nosocomial pathogen that relies on three 
cell-to-cell signals to regulate multiple virulence factors.  The Pseudomonas quinolone 
signal (PQS, 2-heptyl-3-hydroxy-4-quinolone) is one of the three intercellular signals 
and it has been shown to be important for pathogenesis of P. aeruginosa.  PQS is 
synthesized by the condensation of anthranilate and a β-keto fatty acid.  In P. 
aeruginosa anthranilate is produced via the kynurenine pathway and the two separate 
anthranilate synthases, TrpEG and PhnAB.  The anthranilate synthase PhnAB is 
important for the synthesis of PQS and is regulated similarly to the PQS biosynthetic 
operon, where PQS acts as a co-inducer for the transcriptional regulator PqsR.  In a 
series of papers by Essar et al. describing the anthranilate synthases in P. aeruginosa, 
they discovered that a tryptophan auxotroph was able to grow on tryptophan deplete 
media with a frequency of 10-5 to 10-6 and revealed that the tryptophan auxotrophy 
revertant produced increased pyocyanin and exhibited constitutive levels of phnA 
transcript (35, 36).  Our lab made several tryptophan auxotrophy revertants and found 
that the source of the reversion mutation was a silent G to A nucleotide conversion in 
the 3’ end of pqsC.  The single nucleotide change resulted not only in increased 
pyocyanin and phnA transcript, but also a three-fold increase in pqsD and pqsE 
transcript.  Through Northern blots, we identified a unique transcript in the tryptophan 
auxotroph revertant that corresponds to the size of pqsD and pqsE.  To determine if the 
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single nucleotide change resulted in the transcription of pqsD and pqsE from a separate 
promoter, we constructed reporter fusions with the pqsD upstream region containing 
wild-type sequence or the reversion we identified.  The single nucleotide change 
resulted in a 40-fold increase in activity from the reporter fusion when compared to the 
wild-type fusion.  These results suggest a new or dysregulated transcript occurs in the 
PQS biosynthetic operon that allows for the constitutive transcription of pqsD, pqsE, and 
phnAB, which would provide for PQS-independent regulation of virulence factors and 
production of anthranilate for basic cellular functions. 
 
3.2 Introduction 
 The Gram-negative bacillus Pseudomonas aeruginosa is a common nosocomial 
pathogen that causes devastating opportunistic infections in immunocompromised 
individuals and chronic infections in cystic fibrosis (CF) patients (10, 72, 112).   P. 
aeruginosa is notoriously resistant to multiple classes of antibiotics making many 
infections difficult to treat.  The ability of P. aeruginosa to evade the immune system and 
cause these serious infections can be attributed to the numerous virulence factors 
employed by the bacteria.  Many of these virulence factors are controlled by the three 
known cell-to-cell signals.  The three known signals compose a complex communication 
network that ensures for precise expression of many genes in P. aeruginosa.  Two of 
the cell-to-cell signaling systems are acyl-homoserine lactone signals that are regulated 
by their cognate transcriptional regulators LasR and RhlR (42, 92).  Together these two 
signaling systems regulate 6 to 11% of the P. aeruginosa genome (107, 122).  The third 
signal is the Pseudomonas quinolone signal (PQS, 2-heptyl-3-hydroxy-4-quinolone) 
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(95).  PQS acts as a coinducer for the transcriptional regulator PqsR, which drives the 
transcription of the PQS biosynthetic gene locus and positively regulates multiple 
virulence factors (33, 41, 64, 75, 85, 88).  PQS has also been shown to be important to 
P. aeruginosa pathogenesis in Caenorhabditis elegans, Drosophila melanogaster, 
lettuce leaf, and mouse infection models (28, 41, 64, 101, 130).  Lastly, PQS has been 
extracted from the lungs and sputum of infected CF patients, further suggesting its 
importance in P. aeruginosa infections (19). 
 With the overwhelming evidence for the role PQS has in virulence and 
pathogenesis, our lab has set out to understand both the regulation of the genes 
required for PQS production and the biosynthesis of PQS.  The biosynthetic genes 
required for PQS synthesis, pqsABCD and pqsH, are also responsible for the 
production of at least 56 other 4-hydroxy-2-alkylquinolines (HAQs) (67, 80).  The 
biosynthesis of all of the HAQ’s depends on the condensation of a β-keto fatty acid and 
anthranilate (5, 18).  The precursor anthranilate is an important branch-point metabolite 
in P. aeruginosa that can either be synthesized into PQS or the amino acid tryptophan, 
as well as catabolized into tricarboxylic acid cycle intermediates (86).  The cellular pool 
of anthranilate in P. aeruginosa is maintained via three separate pathways (37).  The 
first pathway is the kynurenine pathway, which catabolizes tryptophan into anthranilate, 
and is the main source of anthranilate for PQS production (37).  This pathway is 
regulated by KynR, which upregulates the pathway genes in the presence of kynurenine 
(59), as well as through direct regulation by LasR (43, 59).  Anthranilate is also supplied 
by the two anthranilate synthases TrpEG and PhnAB, which convert chorismate into 
anthranilate.  TrpEG catalyzes the first step in tryptophan synthesis and is regulated by 
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tryptophan through attenuation and post-translational competitive inhibition of TrpE 
(100, 116).  Though this enzyme could provide anthranilate to the cellular pool, previous 
data from our lab suggests that TrpEG is unable to provide anthranilate for PQS 
production (37).  PhnAB is the secondary anthranilate synthase in P. aeruginosa and 
was first described by Essar et al. (35).  PhnAB is encoded directly downstream from 
the PQS biosynthetic operon and is important for the production of anthranilate for PQS 
biosynthesis (37, 80).  The transcriptional regulation of phnAB is similar to the regulation 
of the PQS biosynthetic locus (13, 121).  The positive influence of PqsR on phnAB 
expression has been noted in both microarray and transcriptional fusion results (13, 29).  
Also, a truncated, recombinant PqsR was shown to bind to the phnA promoter, but a 
PqsR binding site has yet to be identified (13).  The influence of LasR, QscR, and RhlR 
on phnA is similar to the regulatory effects that these three transcription factors have on 
the PQS biosynthetic operon.  LasR positively influences phnAB expression, but RhlR 
and QscR negatively effect the expression of phnAB (16, 86).  Whether the influences 
of these transcriptional regulators are due to direct regulation or through regulation of 
PqsR is not known.  The transcription of phnAB follows that of PQS production, where 
phnAB expression increases during late exponential growth and peaks in stationary 
phase (13).  Due to both the location and regulation of phnAB, it was assumed that 
PhnAB provided the majority of anthranilate for PQS synthesis, yet it was shown to only 
be a main source of anthranilate for PQS under nutrient limiting conditions (37).  With 
three separate and uniquely regulated pathways to anthranilate, it is clear that 
production of anthranilate is important to P. aeruginosa survival both for basic cellular 
functions and the production of PQS.  
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 In a series of papers describing both TrpEG and PhnAB, an interesting finding 
about phnAB regulation was revealed (35, 36).  When a tryptophan auxotroph was 
plated on tryptophan deplete media, auxotrophy-negating mutations occurred at a 
frequency of 10-5 to 10-6 (35).  When one of the revertants was investigated, it was 
discovered that it had constitutive levels of phnAB transcript expression, as opposed to 
the peak stationary levels exhibited by wild-type P. aeruginosa (35).  Also, the revertant 
had increased levels of pyocyanin, a virulence factor influenced by the PQS signaling 
system.  Our lab found the results of the tryptophan auxotroph revertant intriguing and 
set out to identify the source of the mutation.  We made tryptophan auxotroph revertants 
and performed whole genome sequencing to identify the mutation.  In this paper, we 
describe the mutation and how it uniquely regulates not only phnAB, but also other PQS 
biosynthetic genes. 
 
3.3 Materials and Methods 
3.3.1 Bacterial strains, plasmids, and culture conditions 
 E. coli and P. aeruginosa strains were freshly plated to begin each experiment 
and were maintained in 30% glycerol and 10% skim milk (Difco) at -80°C, respectively.  
All strains and plasmids used are listed in Table 3.1.  Bacteria were cultured at 37°C in 
Luria Bertani medium (LB) or Vogel Bonner minimal media supplemented with 0.5% 
glycerol (VBG) (120).  Growth of bacterial cultures was monitored 
spectrophotometrically based on the optical density at 600 nm (OD600) for E. coli and 
OD660 for P. aeruginosa.  To maintain plasmids, 100 µg/ml of ampicillin or 200 µg/ml of 
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Table 3.1. List of strains and plasmids used in this study. 
Strain or Plasmid Relevant genotype or phenotype  Reference  
Strains 
    E. coli DH5α 
 
 
 
    P. aeruginosa  
        PAO1 
        PJF-QR1 
        PAΔTrpE 
        PME-QD1 
        PJF-QE1 
        PJF-PhnA 
        PAQC-G1041A 
 
        TrpErev1 
 
        TrpErev2 
 
        TrpErev3 
 
        TrpErev4 
 
        TrpErev5 
 
Plasmids 
    pLP170 
    pPqsDwtTcLacZ 
    pPqsDG1041ATcLacZ 
 
    pEX18AP 
    pPAQC-G1041Adel 
    ptrpEdel 
    pΔpqsD-suc 
    pDSW8 
    pBluescript II SK+ 
 
    pSLM100 
 
 
F’/endA1, hsdR17, supE44 thi-1, recA1, gyrA, 
relA1, (lacZYA-argF) U169, deoR 
[Φ80dlacΔ(lacZ)M15recA1 
 
 
Wild-type 
pqsR deletion mutant derived from strain PAO1 
trpE deletion mutant derived from strain PAO1 
pqsD deletion mutant derived from strain PAO1 
pqsE deletion mutant derived from strain PAO1 
phnA deletion mutant derived from strain PAO1 
G to A mutation in pqsC at base pair 1041 
derived from strain PAO1 
Selective pressure mutation(s) derived from 
strain PAΔTrpE*  
Selective pressure mutation(s) derived from 
strain PAΔTrpE * 
Selective pressure mutation(s) derived from 
strain PAΔTrpE * 
Selective pressure mutation(s) derived from 
strain PAΔTrpE * 
Selective pressure mutation(s) derived from 
strain PAΔTrpE * 
 
LacZ transcriptional fusion vector, Ampr 
pqsD’-lacZ transcriptional fusion, Ampr 
pqsDpqsCG1041A1041’-lacZ transcriptional 
fusion, Ampr 
Suicide vector, Ampr 
G to A reversion in pqsC suicide vector, Ampr 
trpE deletion suicide vector, Ampr 
pqsD deletion suicide vector, Ampr 
tacp-pqsR on pEX1.8, Ampr 
Cloning vector, Ampr 
 
phnA expression vector, Ampr 
 
(129) 
 
 
 
 
(53) 
(38) 
This study 
(38) 
(37) 
This study 
This study 
 
This study 
 
This study 
 
This study 
 
This study 
 
This study 
 
 
(98) 
This study 
This Study 
 
(51) 
This study 
This study 
(121) 
This study 
Aligent 
Technologies 
This study 
Abbreviations: Ampr, ampicillin 
*See Table 3.3 for the location of mutation(s)  
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Table 3.2.  List of primers used in this study.  
Primer use and name Sequence (5’ to 3’)a 
 
Primers for Mutagenesis 
    TrpEF1-HindIII 
    TrpEdelF2 
    TrpEdelR1 
    TrpER2-HindIII 
    PqsCUp1 
    PqsCDown2 
    PqsD UP-O 
    PqsD UP-I 
    PqsD DOWN-O 
    PqsD DOWN-I 
 
Expression plasmids 
    pqsClacZfwd 
    pqsClacZrev 
    phnAXba1up 
    phnAHindIIIdown 
 
EMSA 
    phnA5fwd 
    phnA5rev 
    phnA8fwd 
    phnA8rev 
    phnA9fwd 
    phnA9rev 
    phnA10fwd 
    phnA10rev 
    pqsAfwd 
    pqsArev 
    EMSApqsCDfwd 
     
Real-Time PCR 
    RPLU RT1 
    RPLU RT2 
    pqsARTF1 
    pqsARTR2 
    pqsCRTF1 
    pqsCRTR1 
    pqsDRTF1 
    pqsDRTR1 
    pqsERTF1 
 
 
AAAAAAGCTTCCTGATCGATGCCTCCGGTC 
TCACCGTTCTTGATCACCGCAGTCGGCAAGGGTCTCGA 
TCGAGACCCTTGCCGACTCGCGGTGATCAAGAACGGTGA 
AAAAAAGCTTACCGGCAACAGCATGGAAC 
AAAAAAGCTTAGATTCCCTCGCACATGCTG 
AAAAAAGCTTACCTCCTCAGGTTTGCGGTA 
AAAAAGCTTTGGCAATTCTGGGGCGTC 
GTCCGGCCAGAACATCGCGTTTCGGCAGGCTGAA 
TTCAGCCTGCCGAAACGCGCGATGTTCTGGCCGGAC 
AAAAAAGCTTTCGCCGCAATGGATGTCC 
 
 
AAAAAGAATTCCCGACCGGCGAGGCCAA 
AAAAAAGCTTTGCTGACCTGGCGTTTCGGC 
TTTTCTAGATGATGACCTGTGCCTGTT 
TTTAAGCTTGTGCAATGCCTCCCTCGA 
 
 
TGCCGACCCTGCTGCAACTG 
CGGGCAGGAAGTCGACGCTC 
CTGAGCGAGGAGCTGCACCG 
TCGCCGCAATGGATGTCCCG 
AGGCGCTGCCTCTGGACTGA 
CAACCCCGCTCACGAGCCAC 
CAGCGGTCGCAATTGGGGGA 
GGCCATGCGCCAGATCGACA 
TACGAAGCCCGTGGTTCT 
TGGGCGAAGCGCGATATT 
GGCGATCGTATCGTCATGGC 
 
 
GGTGGCAAGCAGCACAAAGTCACCG 
GCGGACCTTGTCGTGACGGCCGTGG 
GCCCTTTGCTCGACGATTTCTCG 
AACCCGAGGTGTATTGCAGGAAACA 
CGAGTCCTGGTGGCAATTCT 
TCAGCATGTCCACGCTATCC 
GTGGATCGTCTGGGCAACAT 
CTCCTCAGGTTTGCGGTACA 
TGATGACCTGTGCCTGTTGG 
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    pqsERTR1 
    phnARTF1 
    phnARTR1 
 
Northern Blot 
    NorthphnAFwd2 
    NorthphnARev2 
    NorthphnARev4 
    NorthpqsDFwd1 
    NorthpqsDRev1 
    NorthpqsDFwd2 
    NorthpqsDRev2 
    NorthpqsEFwd1 
    NorthpqsERev1 
    NorthpqsEFwd2 
    NorthpqsERev2 
 
Primer Extension 
    PEpqsD1 
    PEpqsD3 
    PEphnA1 
    PEphnA2 
    PEphnA3 
    PEphnA4 
    PEphnA5 
    PEphnA6 
    PEphnA7 
    PEphnA8 
 
Reverse-Transcriptase PCR 
    E1 
    E2 
    F1  
    F2 
     
GTCGTAGTGCTTGTGGGTGA 
ACGTGGACAGCAAGGCTGCG 
GGGCCGGACAGTCCTCGCTC 
 
 
AGGAAGAGTCGCATGCGGAC 
GACCTGGTAGTTGCCGGCCCGTACG 
GATGTCCAGCAGCAACTCCG 
CGCTATCACGTCGAGCCGGAAC 
GCGAACCTGTCGTGGAGCG 
GCGAGGTGCTGTCCAAGCG 
CGCAGGACATTCTCGTCGAGG 
AGGTGCCGGTGTTCCTGCTG 
GGACCTGTACGTTCGGCAGC 
GTGGTCGAGCGCTTGAACCG 
TCGAACTCGCCCAGGGCATC 
 
 
AGGATCGGATTACCCATGTGCAG 
ATGTGCAGCCCTCCTCGGACA  
AACCCCGCTCACGAGCCACC 
AGCCACCTCCTCGCGCCCAT 
AGTCGAACAGCATCCGGTTGGC 
CGATCGCCGCAATGGATGTCCC 
GCGCAACGGCATGTTCATCATCGG 
AGAGAATCTCCAGCATCCGGCGC 
AGGAAGTCGACGCTCTGCCC 
AGAGCAACCGCCGGCACA 
 
 
CCACGGCCACAGCGACGATCA 
CCAGACTTTCTTCCAGTCGATAGC 
(80) 
(80) 
aRestriction sites indicated by bold type.  
62 
carbenicillin was added when appropriate.  Also, 10 mM L-tryptophan was added to 
VBG cultures when indicated.  
 Generation of a transcriptional fusion for pqsD, a 499 bp DNA fragment, 
extending from begins 441 bp upstream of the pqsD start codon (ATG) to 58 bp 
downstream of the ATG, was amplified by PCR using chromosomal DNA as a template 
from either strain PAO1 or TrpErev1.  The oligonucleotide primers used for the 
amplification contained either an EcoRI (pqsClacZfwd) or a HindIII (pqsClacZrev) 
restriction site (Table 3.1).  The amplified fragment was digested with EcoRI and HindIII, 
purified from an agarose gel, and ligated into pLP170 digested with the same enzymes.  
This resulted in the reporter plasmids pPqsDwtTcZ and pPqsDG1041ATcZ.  Both 
fusions were sequenced to ensure that mutations did not occur during cloning.  
Plasmids were transformed into P. aeruginosa strains by electroporation (33). 
The plasmid pSLM100 was used as a sequencing template for phnA primer 
extensions.  The DNA fragment, which begins 993 bp upstream from the ATG and 1000 
bp downstream from the stop codon, was created by PCR using strain PAO1 
chromosomal DNA as a template.  The primers used are noted in Table 3.2 and added 
an XbaI to the 5’ end and a HindIII to the 3’ end for the PCR product.  The DNA 
fragment and pBluescriptIIsk+ were digested with the two restriction enzymes and 
ligated together. 
3.3.2 Generation of mutants 
 A splicing by overlap extension protocol was used to generate mutant alleles for 
both the trpE and pqsD deletion strains (126).  The mutations were constructed to 
contain in-frame deletions in the coding DNA sequences corresponding to amino acids 
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26 to 445 for trpE (85% of protein sequence) and 16 to 298 for pqsD (83% of protein 
sequence).  Primers were designed to contain approximately 1 kb of DNA both 
upstream and downstream from the splice junction and each primer added a HindIII 
restriction site to both ends of the PCR product.  Both PCR fragments and pEX18Ap 
(suicide vector) were digested with HindIII and ligated together to make the suicide 
vectors ptrpEdel and pΔpqsD-suc.  To generate the PAQC-G1041A mutant, a PCR 
fragment was created using TrpErev1 and the primers listed in Table 3.2.  The PCR 
fragment was digested with HindIII and then ligated into similarly digested pEX18AP.  
The resulting plasmids, ptrpEdel, pΔpqsD-suc and pPAQC-G1041A, were transformed 
into strain PAO1 by electroporation (15).  Mutants were selected for by plating 
transformants on a medium containing carbenicillin and then on a medium containing 
6% sucrose to remove the vector sequence (51).  PCR was used to screen colonies 
and DNA sequencing of PCR products was used to confirm mutants. 
 Tryptophan auxotroph revertants were made through selective pressure on 
media deplete of tryptophan.  The tryptophan auxotroph strain PAΔTrpE was grown 
overnight in VBG supplemented with 10 mM L-tryptophan at 37°C with ≥180 rpm 
shaking.  Overnight cultures were washed with fresh, unsupplemented VBG and 100 µL 
of washed culture was added to 10 ml of unsupplemented VBG.  The culture was grown 
for 3 h at 37°C with ≥180rpm.  After 3 h of growth, cells were harvested at 6,000 x g for 
10 min.  The cell pellet was resuspended in 1 ml of VBG and then plated onto VBG 
plates.  The random mutations were then identified through Illumina sequencing and 
bioinformatics performed by the Genomic Sciences Laboratory at North Carolina State 
University. 
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3.3.3 PQS production 
Washed cells from overnight cultures were used to inoculate 10 ml cultures of LB 
or VBG to an OD660 of 0.05.  After 24 h of growth, 300 µl samples of each culture were 
extracted with 900 µl of acidified ethyl acetate as previously described (20).  One-half of 
the resulting organic phase was evaporated to dryness at 37°C and 50 µl of 1:1 
acidified ethyl acetate:acetonitrile was used to reconstitute the extract (19).  Samples 
were analyzed by thin-layer chromatography, visualized by long-wave UV light, and 
photographed (20). 
3.3.4 RNA isolation 
 For all RNA extractions the cultures were grown at 37°C in either LB or VBG 
media until an OD660 of 0.2 or 0.6 was reached.  At that point total RNA was isolated 
using multiple methods. RNA for RT-PCR and real-time PCR was purified using the 
RNeasy mini spin columns (Qiagen).  RNA for the northern and primer extension 
experiments was either isolated using a RNeasy midi column (Qiagen) or through Trizol 
isolation (Invitrogen).  For Trizol isolation, RNAprotect (Qiagen), two times the volume of 
the culture, was added and allowed to incubate at room temperature (RT) for 5 minutes.  
The cells were harvested by centrifugation at 6,000 x g for 5 minutes.  The cells were 
then suspended in lysis buffer (30 mM Tris pH 8.0, 1 mM EDTA, 10 mg/ml Lysozyme, 
and 2 mg/ml Proteinase K) and allowed to react for 5 min at RT.  Then 2.5 times the 
culture volume of Trizol was added to the lysed cells and incubated for 5 minutes at RT.  
After incubation, 0.2 volumes of chloroform was added, vigorously shaken, and then 
incubated at RT for 2 to 3 minutes.  The mixture was centrifuged at 12,000 x g for 15 
minutes at 4°Cj and the aqueous phase was removed.  Next, 0.5 vol of isopropanol was 
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added to the aqueous phase and this was centrifuged at 12,000 x g for 20 minutes at 
4°C to pellet RNA.  The pellet was washed with 75% EtOH-DEPC and centrifuged for 
15 minutes at 12,000 x g at 4°C.  RNA pellets were dried at 37°C and resuspended in 
DEPC-treated water.  All RNA samples, regardless of the purification method, were 
treated with RQ1 DNase (Promega) for 2 hours at 37°C.  To remove RQ1 DNase, 
phenol/chloroform extraction was performed, followed by an ethanol precipitation.  RNA 
was stored in DEPC-treated water at -80°C.  
3.3.5 Real-Time RT-PCR (qRT-PCR) 
cDNA synthesis was performed on a Mastercycler (Eppendorf) using 2.5 µg of 
DNase-free RNA.  The cDNA was made using Superscript III (Invitrogen) following 
manufactures instructions.  Primers to generate cDNA were Random Primers 
(Invitrogen), as well as Random Hexamers 72% GC (Gene Link).  qRT-PCR was 
performed on a CFX96 (BioRad) using the PerfeCTa SYBR Green FastMix for iQ 
(Quanta Biosystems).  The qRT-PCR reactions contained 5 µl of cDNA diluted (1:500) 
in a 15 µl volume.  Relative transcript levels were determined using the Pfaffle method 
by comparing experimental gene expression (phnA, pqsA, pqsC, pqsD, or pqsE) to the 
control gene rplU (97).  Standard curve and efficiency values were determined by using 
gene-specific primers with 10 ng to 0.1 pg of RNA-free genomic DNA from strain PAO1.  
A melting curve step was included at the end of each PCR to ensure that nonspecific 
variation between samples, as well as the absence of primer dimers did not occur.  
Each qRT-PCR was performed on at least three biological replicates of each RNA 
sample with technical replicates performed in duplicate. 
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3.3.6 RT-PCR 
 For reverse transcriptase-PCR, the AccessQuick Kit from Promega was used.  
100 ng of PAO1 chromosomal DNA was used as a positive control and 300 ng of RNA 
was used in all experimental samples.  Two biological RNA samples per strain were 
used to verify results.  Primers utilized in the assay are noted in Table 3.2.   
3.3.7 Northern Blot 
 RNA was purified from strain PAO1, PJF-PhnA, PME-QD1, PJF-QE1, and 
TrpERev1 from cultures grown in VBG at 0.6 OD660 as stated previously.  RNA (30 µg of 
sample RNA and 5 µg Ambion millennium marker) was electrophoresed on a 6% 
formaldehyde-1X DEPC-MOPS -1% agarose gel at 100V for 10 minutes followed by 
35V overnight.  Samples were photographed under UV light.  Downward alkaline 
transfer onto a BrightStar-Plus membrane (Ambion) was used to transfer the RNA from 
the gel to the membrane according to manufactures instructions.  RNA was crosslinked 
by exposing the membrane to UV light.  DNA fragments for Northern probes were 
synthesized by PCR using strain PAO1 chromosome as a template and then were 
labeled with [α-P32] CTP (Pierce) using the Prime-a-Gene system (Promega).  
Hybridization of the labeled probes to the membrane was done according to the 
manufactures protocol (BrightStar-Plus membrane, Ambion).  The membranes were 
then exposed to film.   
3.3.8 Primer Extension 
 RNA was purified as stated previously.  Primers used for primer extension are 
listed in Table 3.2. Primers were radiolabeled using [γ-32P]ATP (Pierce) and T4 
polynucleotide kinase (Invitrogen).  A sequenase Cycle Sequencing Kit (USB Thermo) 
67 
was used according to the manufacturer’s instructions to sequence DNA using 
pSLM100 (for phnA) and ppqsCG1041Adel (for pqsD) as template.  The only deviation 
from the protocol is ddNTPs from USB Affymetrix were used instead of those included 
in the kit.   For the extensions, between 30-80 µg of total RNA was used, primers were 
annealed, and Superscript III Reverse Transcriptase (Invitrogen) was used to extend 
each primer.  The sequencing and extension reactions were electrophoresed as stated 
previously (94). 
3.3.9 β-galactosidase (β-gal) assays in P. aeruginosa 
 Cells from overnight cultures of P. aeruginosa grown in VBG were washed and 
resuspended in fresh medium to an OD660 of 0.05 and incubated at 37°C with shaking at 
≥180 rpm for 6 h.  At that time either water or 1 mM L-kynurenine was added and 
cultures continued to grow at 37°C with shaking at ≥180 rpm for an additional 18 h.  The 
cells were collected by centrifugation at 12,000 x g for 2 min, resuspended in fresh 
VBG, and assayed for β-gal activity in duplicate.  Data are presented in Miller units as 
the mean ± the standard deviation (σn-1) of at least three separate experiments. 
3.3.10 Overproduction and Purification of PqsR.  
Plasmid pDSW8 in E. coli strain DH5α (Table 3.1) was used for over-expression 
of PqsR.  Culture medium (500 ml LB with 100 µg/ml ampicillin) was inoculated with 10 
ml overnight culture and grown on a rotary shaker at 250 rpm at 37°C to 0.6 OD600 nm.  
Cultures were cooled to room temperature and IPTG was added to a final concentration 
of 0.5 mM.  Growth was continued at 25°C on a rotary shaker for 2 h.  Cells were 
harvested by centrifugation at 4°C, washed once with phosphate-buffered saline, and 
stored at -20°C. 
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For protein purification, cell pellets (~2.5 g) were resuspended in 20 ml TES 
buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 5 mM EDTA, 1 mM DTT) containing 
0.02% Tween 20 and 10 µl/ml HALT protease inhibitor (Thermo Scientific) and passed 
twice through a French pressure cell at 12,000 lb/in2.  Following incubation on ice for 30 
min, cell debris was removed by centrifugation at 10,000 x g for 30 min.  The 
supernatant was removed and the protein concentration estimated by measuring 
absorbance at 280 nm.  The sample was adjusted to a protein concentration of 2 mg/ml 
by addition of TES + 0.02% Tween 20.  Solid ammonium sulfate was then added to 
35% saturation.  After incubation at 4°C for 30 min, the suspension was centrifuged at 
10,000 x g for 30 min.  The pellet was resuspended in 25 ml Buffer A (20 mM Tris-HCl, 
pH 7.0, 1 mM EDTA, 1 MM DTT, 10% glycerol) and dialyzed 3 h or overnight against 
the same buffer.  The dialysate was centrifuged for 10 min to remove any precipitate 
and applied to a Buffer A-equilibrated heparin agarose column (4.6 mm x 5.5 cm) at a 
flow rate of 0.5 ml/min.  The run-through was reapplied to the column once and the 
column was then washed with Buffer A until the A280 nm reading reached a stable 
baseline.  Proteins were then eluted with a 150 ml linear gradient of 0 – 1 M NaCl in 
Buffer A.  Fractions of ~3.5 ml volume were collected and the presence of PqsR was 
determined by SDS-PAGE and mobility shift assays.  PqsR eluted at approximately 0.5 
M NaCl.  Samples were stored at -20°C. 
3.3.11 Electrophoretic Mobility Shift Assays (EMSA).   
Labeled probes were prepared by ϒ-32P-ATP / T4 polynucleotide kinase labeling 
of PCR amplified promoter fragments (Table 3.2 , note that PEpqsD1 was used with 
EMSApqsCDFWD to make the pqsCD probe).  For all promoter fragments strains PAO1 
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chromosome was used as template, with the exception of the G1041A mutated pqsD 
promoter in which chromosomal DNA from strain TrpERev1 was used.  EMSA was 
performed on 6% polyacrylamide gels (5% crosslinker) containing 2.5% glycerol and 
running buffer containing 25 mM Tris, 0.19 M glycine, and 1 mM EDTA.  Gels were pre-
run at 4°C for 30 min before loading.  Binding reactions (15 µl) contained 1 nM 32P-
labeled probe, 100-200 ng purified PqsR, 20 mM Tris·HCl, pH 7.5, 50 mM KCl, 1 mM 
EDTA, 1 mM DTT, 100 µg/ml acetylated BSA, 10 µg/ml poly(dIdC) and 5% 
glycerol.  Samples were incubated for 20 min at 25°C and then loaded.  Electrophoresis 
was conducted at 4°C at 10 V/cm and then gels were soaked in 10% methanol – 5% 
acetic acid for 15 minutes, blotted dry, covered with plastic wrap; and exposed to X-ray 
film. 
3.4 Results 
3.4.1 A conserved mutation rescues a tryptophan auxotroph.  
 P. aeruginosa possesses two anthranilate synthases, TrpEG and PhnAB.  The 
existence of two anthranilate synthases, as well as the kynurenine pathway, ensures 
that the cellular pool of anthranilate can be maintained for tryptophan synthesis, PQS 
production, and the use of anthranilate as a carbon and nitrogen source.  In the series 
of papers describing both TrpEG and PhnAB, Essar et al. discovered that a tryptophan 
auxotroph reverted to tryptophan prototrophy at a high frequency (10-5 to 10-6) when 
grown on tryptophan deplete media (35, 36).  The tryptophan auxotroph revertant 
exhibited increased pyocyanin and constitutive levels of phnAB transcript, which was 
dysregulated to provide anthranilate for the synthesis of tryptophan and ensure survival   
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Figure 3.1 Under tryptophan starvation, a mutation in a tryptophan auxotroph results in 
increased pyocyanin and decreased PQS.  (A) Pyocyanin production after 18 h growth 
in LB.  Results shown are the mean ± σn-1 of results from duplicate assays from at least 
three separate experiments.  (B and C) Ethyl acetate extracts from cultures grown in LB 
(B) and VBG (C) after 24 h were analyzed by TLC. Equal volumes of extracts were 
resolved in each lane.  For B:  Lane (1) 50 ng of synthetic PQS, (2) strain PAO1, (3) 
strain PAΔTrpE, (4) strain PAQC-G1041A, and (5-9) strains TrpErev 1,2,3,4, and 5.  For 
C: Lane (1) 50 ng of synthetic PQS, (2) PAO1, (3) PAQC-G1041A, and (4-8) TrpErev 1, 
2,3 4, and 5.  
A 
1    2     3    4    5    6    7    8    9 
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(35).  The exact revertant strain is no longer available, so our lab selected revertants in 
the same manner and set out to identify the mutation(s) responsible for the loss of 
tryptophan auxotrophy.  In order to do this we constructed a tryptophan auxotroph 
(PAΔTrpE) and grew it on minimal media deplete of tryptophan.  This was repeated 
three times and we selected five revertants to analyze.  All five tryptophan revertants 
showed increased pyocyanin as seen by Essar et al. (35). up to double that of the wild-
type strain PAO1 (Figure 3.1).  Pyocyanin is linked to PQS production through the 
expression of pqsE, which is transcriptionally connected to pqsABCD and necessary for 
pyocyanin to be produced (31, 41). It is because of this link that we investigated the 
production of PQS in each of the tryptophan revertants.  All of the revertants made 
PQS, albeit at a decreased level in both complex (Figure 3.1B) and tryptophan deplete 
media (Figure 3.1C).  The decreased PQS in the tryptophan revertants was more 
pronounced when extracted from complex media than in the tryptophan deplete media.  
These results were unexpected because the PQS operon must be expressed to allow 
for pyocyanin, yet we observed decreased PQS production, which implies that the 
mutation in the tryptophan auxotroph revertants may also affect the PQS biosynthetic 
operon.   
 When analyzing their revertant, Essar et al. performed RNA slotblots to show that 
phnAB transcription had increased during exponential phase (35).  To determine if our 
revertants had a similar change in phnAB transcript levels, we extracted RNA from the 
revertants grown in either complex or tryptophan deplete media to an OD660 of 0.2 or 
0.6 and performed quantitative real-time PCR.  These time points were based on the   
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Figure 3.2: The mutation in the tryptophan auxotroph revertants results in increased 
phnA transcript levels.  Real-time PCR was used to measure the expression of phnA 
mRNA from the indicated strains grown at 37°C in LB (A) and VBG (B).  Wild-type strain 
PAO1 transcript levels are set at 1, which is indicated by the dashed line.  Error bars 
indicate the standard deviation of three independent experiments performed in 
duplicate.  
  
A 
B 
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slot blot results presented by Essar et al., which showed a respective eight or four fold 
increase of phnA transcript in the revertants compared to wild-type the during early 
exponential and late exponential phases (35).  The real-time data for RNA extracted at 
OD660 0.2 are shown in Figure 3.2 A and B.  The results indicate that in either media the 
phnA transcript is greater in our revertants.  As a control, phnA expression in the 
tryptophan auxotroph strain PAΔTrpE grown in LB is shown in Figure 3.2A.  This control 
was not performed in VBG because this media is deplete of tryptophan and the strain 
would not have grown without tryptophan supplementation.  The results indicated that 
phnAB levels are lower in the trpE mutant strain when compared to wild-type strain 
PAO1 grown in the same media.  As stated above, the assay was also performed on 
RNA isolated from cultures at an OD660 of 0.6 in both media, and those results mirrored 
the data of Figure 3.2 (data not shown).  Our real-time data confirmed that each of our 
tryptophan auxotroph revertants had increased expression of phnA during early growth 
phases and agrees with the data reported by Essar et al. (35).  Taken together, our data 
lead us to believe that we are studying the phenomenon first reported by Essar et al. 
and that an unknown regulatory event occurs when cells are starved for tryptophan (35).  
 To understand what has happened in the revertant stains, the full genome 
sequence of the first three tryptophan revertants was determined.  An Illumina GAIIX at 
the North Carolina State University Gene Sequencing Laboratory was used to sequence 
the wild-type strain PAO1 and three revertants (TrpErev1, 2, and 3).  The sequencing 
provided between 5.8 and 7.3 million reads for a high quality map.  To determine the 
location of the mutation(s), the published wild-type strain PAO1 genome from   
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Table 3.3 Location of the mutation(s) in tryptophan auxotroph revertants. 
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www.pseudomonas.com was compared to the sequenced lab wild-type PAO1 strain 
and tryptophan revertant strains.  The Burrows-Wheeler Aligner (BWA) was used to 
align the raw reads and provided the high quality map (68).  The trpE deletion in each of 
the revertants was confirmed by using the Integrative Genomics Viewer (IGV) (103, 
118).  Both Joint Genotyper for Inbred Lines (JGIL) and SAMtools/BCFtools were used 
to identify single nucleotide polymorphisms (SNP) and the SAMtools/BCFtools were 
used specifically to identify any insertions and/or deletions (69, 111).  The JGIL is 
designed to look for SNPs in inbred lines, but is appropriate to use for bacteria due to all 
strains being derived from the same parent strain.  The two programs each identified 
two SNPs shown in Table 3.3 and no insertions or deletions were noted.  The SNP at 
pqsC nucleotide 1041 had over 100 depth of coverage and SNP at ntrC nucleotide 1227 
had over 55 for each of the revertants and wild-type strain PAO1.  Once the location of 
the SNPs were identified the TrpErev4 and TrpErev5 strains were sequenced 
separately using PCR fragments.  The results are shown in Table 3.3.  The only SNP 
that occurred in all five strains was the G to A conversion at basepair 1041 of pqsC.  
Due to the G1041A mutation in pqsC occurring in all five tryptophan auxotroph revertant 
strains and the fact that it is relatively close to phnA, we felt it warranted further 
investigation.  The G1041A mutation is two amino acids from the PqsC stop codon and 
is in the third base of a valine codon, resulting in a silent mutation.  There is a 43 base 
pair intergenic region between the termination of the pqsC coding sequence and the 
start codon of pqsD, so this change does not affect the PqsD protein.  To ensure that 
the G1041A mutation in pqsC resulted in the effects observed in the tryptophan 
auxotroph revertants, we created a mutant that contained only the G1041A mutation.  
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Most interestingly, the G1041A mutation resulted in increased pyocyanin (Figure 3.1A), 
decreased PQS (Figure 3.1 B lane 4 and C lane 3), and increased phnA transcript 
(Figure 3.2 A and B).  This confirmed that a single base change at nucleotide 1041 of 
pqsC caused the observed results and is a mechanism by which P. aeruginosa can 
survive when starved for tryptophan, and probably anthranilate.  Our next goal was to 
try to understand how this single base change allows this to occur.  
3.4.2 A silent mutation in pqsC results in differential expression within the PQS 
biosynthetic operon. 
 The G1041A mutation in pqsC affected the production of pyocyanin and PQS so 
we decided to investigate the transcription levels of the PQS biosynthetic operon genes.  
We utilized quantitative real-time PCR to look at the transcript levels of pqsA, pqsC, 
pqsD, and pqsE.  The level of pqsB transcript was not investigated because we wanted 
to specifically look at the first gene in the operon (pqsA) and the genes that may have 
been affected by the mutation (pqsC, D, and E).  As above, RNA was taken at an OD660 
of 0.2 in both LB and VBG media.  The results from the quantitative real-time PCR are 
shown Figure 3.3 A and B.  These data show that both the G1041A mutant (PAQC-
G1041A) and the tryptophan auxotroph revertant (TrpErev1) have a greatly decreased 
level of pqsA transcript when compared to the wild-type strain PAO1.  The decrease in 
pqsA transcript is likely due to lower PQS levels resulting in less co-inducer for the 
transcriptional regulator PqsR to drive transcription of pqsA (121).  The most striking 
results were that both pqsD and pqsE transcript levels were increased three fold in both 
strain TrpErev1 (Figure 3.3A) and strain PAQC-G1041A (Figure 3.3B) when compared 
to the wild-type strain PAO1.  This result is perplexing because previous data suggested   
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Figure 3.3 The expression of pqsD and pqsE is increased by the single nucleotide 
mutation in pqsC.  Real-time PCR was used to measure the expression of pqsA, pqsC, 
pqsD, and pqsE mRNA from strains TrpErev1 (A) and PAQC-G1041A (B) grown at 
37°C in VBG to an OD660 of 0.2.  Wild-type strain PAO1 transcript levels are set at 1, 
which is indicated by the dashed line.  Error bars indicate the standard deviation of 
three independent experiments performed in duplicate. 
  
A 
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that the PQS biosynthetic operon transcript is derived from the pqsA promoter and that 
the transcript included all five genes (80).  A recent transcriptome analysis of 
transcriptional start sites in P. aeruginosa strain PA-14 suggested that an alternative 
start site for the PQS biosynthetic operon was located upstream from pqsB (32).  This 
alternative start site could not account for the differential levels in transcript between 
pqsA and pqsD/E because the levels of pqsC transcript are also significantly decreased 
in both mutants.  All of the real-time results in LB mimicked those of VBG and are not 
shown.  Our results suggest that the G1041A mutation results in (1) the induction of a 
transcript upstream from pqsDE or (2) stabilization of the pqsDE transcript.   
Due to the increased levels of pqsDE transcript, along with phnA, it is possible 
that the mutation has allowed for a new transcript including pqsDE and phnAB.  To first 
investigate this possibility, we employed reverse transcriptase PCR (RT-PCR)(Figure 
3.4 B).  The oligionucleotides used for RT-PCR are illustrated in Figure 3.4 A and 
included a set from the paper by McGrath et al., who had previously used the 
oligionucleotides to determine that the PQS biosynthetic operon only included 
pqsABCDE and not phnAB.  The results from the RT-PCR were surprising and 
contradicted what had been published by McGrath et al.  The RT-PCR, using four 
separate oligionucleotides in three different combinations, suggests that there is a 
transcript between our outermost oligonucleotides, not only in the G1041A mutation 
strain PAQC-G1041A, but also in wild-type strain PAO1.  These results were also 
confirmed in an independent RNA extraction from each strain.  The outermost 
oligionucleotides (Figure 3.4A, E1 and F2) are 556 nucleotides upstream from the phnA 
start codon (438 nucleotides of the pqsE genes) and 468 nucleotides downstream from   
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Figure 3.4: Analysis of the pqsE and phnA transcript by RT-PCR.  A.) Diagram 
indicating the location of the primers (primer sequences are shown in Table 3.2)  B.)  A 
1.0% agarose gel was loaded with products form RT-PCR experiments performed with 
the indicated oligonucleotide primer pairs shown in A.  Lanes 3 and 4 contain total RNA 
from wild-type strain PAO1 and lanes 5 and 6 contain total RNA from the strain PAQC-
G1041A. RNA was isolated from VBG media at an OD660 of 0.2.  Total RNA was used 
as a template for experimental reactions (lanes 3 and 5 in each panel).  Chromosomal 
DNA was used as a template for positive control reactions (lane 2 in each panel).  For 
negative controls, reverse transcriptase was omitted from reactions (lanes 4 and 6 in 
each panel).  Lane 1 contains molecular mass standards (1 kb DNA plus ladder, 
Invitrogen) and relevant standards are marked on the left side of each panel.   
1       2      3        4       5       6  
1000 
850 
650 
500 
  1       2         3        4        5        6  
850 
650 
500 
1000 B 
1000 
850 
1600 
1         2        3         4          5       6     
    pqsD pqsE phnA phnB 
E1 F1 E2 F2 A 
E1, E2 F1, F2 
E1, F2 
80 
the phnA ATG. Three possibilities are likely for the RT-PCR results: (1) either phnA has 
a large leader sequence on the transcript, (2) pqsE has over a 500 basepair tail on the 
transcript, or (3) that pqsE and phnAB are transcribed together. The results are 
perplexing as a previously reported phnAB-lacZ fusion was active and a transcriptional 
start site would have to be upstream from phnA in order to have an active fusion for the 
bioassay (13).  Our lab has also utilized a plasmid that only included the phnAB coding 
region and was able to complement a phnA mutant, which would also suggest that there 
is a separate transcriptional start site for phnAB (37).  Our lab has attempted to identify 
a transcriptional start site by utilizing primer extension, as well as other methods, but we 
have not been successful (data not shown).  The only thing that we can conclude from 
the RT-PCR results is that there is a transcript between the two outermost 
oligonucleotides, but what is contained on that transcript is unknown. 
To help understand the RT-PCR results, we performed Northern blots probing for 
phnA, pqsD, and pqsE (Figure 3.5 B).  In our Northern blots, we included a negative 
control using RNA isolated from an isogenic deletion mutant strain for each probe, 
which ruled out non-specific binding for our probes.  For the phnA blot (Figure 3.5B, left 
panel), our results indicate that the phnA probe is binding specifically to a transcript that 
is centered at approximately 2 kilobases (kb).  This size would account for the coding 
regions of phnAB together, which is 2174 nucleotides long, but does not account for any 
mRNA leader or tail.  Our blot also suggests that the transcript(s) that contains phnA is 
unstable as the probe bound to transcript(s) extending from above 3.5 kb to below 1 kb 
(Figure 3.5B, left panel), which indicated that the transcript(s) is at least 3.5 kb.  Yet, we 
can conclude that the G1041A mutation did not result in a notable change in the phnA   
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Figure 3.5 Northern blot results reveal a novel transcript that contains pqsD and pqsE. 
(A) A map of the probe locations for the pqsD, pqsE, and phnA pictured Northern blots.  
A second set of probes for each blot were also used (not pictured) and all primers for 
the blots are indicated in Table 3.2  (B) Northern blot results for phnA, pqsD, and pqsE 
of RNA extracted from cutlures grown in VBG to an OD660 of 0.2 extracted from the 
indicated P. aeruginosa strains.  The arrows indicate the light band the novel pqsDE 
transcript.  
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transcript(s) or stability as both the wild-type strain PAO1 and strain TrpErev1 blots are 
nearly identical (Figure 3.5B, left panel).  We also performed Northern blots with pqsD 
and pqsE probes to further investigate the RT-PCR results and determine the size of 
the transcript(s) containing these genes (Figure 3.4B, center and right panels).  The 
blots did not aid in clearing up the transcript(s) size as they both contain a smear from 
above 3 kb and below 1 kb and again suggest that the transcript(s) are unstable.  One 
surprise is that no transcript(s) are indicated above 4 kb in the pqsD and pqsE blots, 
which would be the size of the pqsABCDE transcript.  Lastly, a band is visible in the 
tryptophan revertant strain TrpErev1, but not the wild-type strain PAO1, in both the 
pqsD and pqsE blots.  This band (indicated by the arrow) is approximately 2 kb in size, 
which would account for the coding regions of pqsD and pqsE (1908 nucleotides), as 
well as for a leader and/or tail on the mRNA.  This fragment could encode for a 
transcript that includes only pqsD and pqsE, and leads us to believe that the mutation 
may have resulted in the creation of a new or dysregulated transcriptional start site 
upstream of pqsD.  
3.4.3 The single nucleotide mutation in pqsC induces transcription of pqsD from a 
new transcriptional start site in the PQS biosynthetic operon. 
 To determine if the 2kb band identified in the pqsD and pqsE Northern blots 
represents a novel transcript containing only pqsD and pqsE, we made a transcriptional 
lacZ fusion containing 500 nucleotides upstream from the pqsD start codon from both 
the wild-type strain PAO1 and the tryptophan auxotroph revertant strain TrpErev1.  The 
resulting transcriptional fusions were electroporated into the wild-type strain PAO1, and 
the β-gal activity of the fusions was assayed at an OD660 of 0.2 in VBG media.  The   
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Figure 3.6 The G1041A mutation results in the transcriptional activation of a new 
transcript upstream from pqsD.  The P. aeruginosa wild-type strain PAO1 with either 
ppqsDwtTcZ (black bar) or ppqsDG1041ATcZ (grey bar) was grown in VBG media until 
an OD660 of 0.2 was reached.  The cultures were then assayed for β-gal activity, which 
is presented in Miller units as the mean ± σn-1 of results from at least three separate 
experiments. 
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results show a 40-fold increase in the activity of the G1041A mutant pqsD-lacZ fusions 
when compared to the wild-type pqsD-lacZ fusion (Figure 3.6).  The assay was also 
performed at an OD660 of 0.6 and after 24 hours of growth in both LB and VBG media 
with identical results (data not shown).  The drastic difference in activity of the two 
fusions suggests that the G1041A mutation has provided an increase in activity of 
ppqsDG1041ATcZ and the G1041A mutation resulted in the transcriptional upregulation 
of pqsD and pqsE from a new transcriptional start site.  These results taken together 
with the increase in pyocyanin (Figure 3.1), decreased PQS (Figure 3.1 A and B), three 
fold increase in pqsD and pqsE transcripts (Figure 3.3), and the band identified in the 
pqsD and pqsE northern blots (Figure 3.5B, center and right panels) would suggest that 
the G1041A mutation in pqsC results in a new transcript that starts upstream from pqsD 
start codon.  We have performed electrophoretic mobility shift assays (EMSA) with 
purified PqsR to see if it regulated the pqsD promoter and no binding was noted (data 
not shown).  We are currently pursuing experiments to identify the transcriptional start 
site of the new promoter and begin searching for possible regulators of this promoter.      
3.5 Discussion    
 The intriguing results reported for the Essar et al. (35) tryptophan revertant left 
our lab wondering what natural event would lead to changes in pyocyanin and phnA 
transcription.  Our isolation of five tryptophan auxotroph revertants that mirrored the 
results shown by Essar et al. suggested that we had recreated the mutation that allowed 
for survival on tryptophan deplete media (Figure 3.1 and Figure 3.2).  Full genome 
sequencing of the revertants led to the discovery of a point mutation in pqsC at 
nucleotide 1041 that occurred in all five examined strains (Table 3.3).  The pqsC 
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G1041A mutation was surprising, but since its location was near phnAB and within the 
PQS biosynthetic operon we believed that it was worthy of investigation.  The G1041A 
mutant strain PAQC-G1041A that we constructed confirmed that the single nucleotide 
change in pqsC was responsible for the increase in pyocyanin production and phnA 
transcription exhibited by our revertants (Figures 3.1 and 3.2).  The second point 
mutation was found in ntrC in only two out of the five strains examined.  This gene 
encodes for the response regulator in a two-component system that regulates nitrogen 
assimilation and is part of an intricate network that balances nitrogen and carbon source 
utilization in P. aeruginosa (70).  This mutation was likely an unrelated secondary 
mutation and could be due to growing under nutrient limiting conditions.  It is also 
possible this was a secondary mutation that resulted from over expression of phnA(B) 
causing increased anthranilate production that shifts the nitrogen and/or carbon source 
demand.  Regardless of what resulted in the ntrC mutation, it is clear that a single 
mutation of a G to A  in nucleotide 1041 of pqsC is sufficient to produce the same 
results as the tryptophan auxtroph revertants. 
Further investigation of the G1041A mutation in pqsC lead us to discover that not 
only was the single nucleotide change responsible for elevated levels of phnA transcript 
and pyocyanin production (Figures 3.1 and 3.2), but it also resulted in dysregulation of 
the PQS biosynthetic operon (Figure 3.3).  The G1014A mutation resulted in decreased 
levels of pqsA and pqsC transcript.  This most likely resulted in decreased co-inducer 
(PQS) for PqsR, the transcriptional regulator of the PQS biosynthetic operon (121).  The 
most striking results were the elevated levels of pqsD and pqsE transcripts (Figure 3.3).  
The elevated level of pqsE transcript explains the increased production of pyocyanin, as 
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pqsE is necessary for the increased production of pyocyanin (38, 41).  The increased 
transcription of pqsE, and likely overproduction of the PqsE protein, may also account 
for the decrease in PQS production in the revertants (Figure 3.1), as it has been shown 
that overproduction of PqsE results in decreased levels of PQS and HAQ’s  (46).   
The elevation of pqsD, pqsE, and phnA transcripts in the G1041A mutant was 
intriguing and led us to believe that the mutation resulted in either a new transcript or 
increased stability of transcript(s) that contained each of the genes.  To elucidate if the 
mutation resulted in a transcript that contained pqsE and phnA(B), which had been 
previously reported to be separate, we utilized RT-PCR (80).  This experiment showed  
that a transcript containing pqsE and phnA was possible.  The RT-PCR also revealed 
that if pqsE and phnA are on the same transcript it was not a result of the G1041A 
mutation in pqsC (Figure 3.4B), as the results were the same in both the wild-type strain 
PAO1 and the G1041A mutant strain PAQC-G1041A.  Our results suggested that pqsE  
and phnA are on the same transcript, yet we believe that a separate promoter for just 
the transcription of phnAB exists.  This has been shown through the activity of phnA 
transcriptional fusions, as well as expression plasmids from previous results by both our 
lab and others (13, 37).  The ability of phnAB to be transcribed both from its own 
promoter and read-through from pqsE transcription would further ensure the production 
of anthranilate for PQS production and basic cellular functions.   
In order to understand the RT-PCR results, we performed Northern blots on 
pqsD, pqsE, and phnA (Figure 3.5B).  In each of the Northern blots, it was clear that the 
transcripts that contained pqsD, pqsE, and phnA were degraded and did not result in 
the conclusion of how many transcripts or an exact size of the transcripts.  We can 
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speculate that the transcript(s) size containing pqsD, pqsE, and phnA are all at least 3.5 
kb (Figure 3.5B).  Previous Northern blot attempts on the PQS biosynthetic locus genes 
by our lab using multiple different probes and RNA extraction methods have 
consistently shown binding that extended from above 4 kb to below 1kb (data not 
shown).  These results further suggested that the transcripts for the biosynthetic locus 
are highly unstable (data not shown).  The Northern blots for pqsD and pqsE from this 
study did show a novel band at approximately 2kb in the tryptophan auxotroph revertant 
strain TrpErev1 that was not in the wild-type strain PAO1 (Figure 3.5, center and right 
panels).  The size of this band suggested that the transcript would contain both pqsD 
and pqsE and led us to the possibility that the G1041A mutation in pqsC resulted in the 
creation of this transcript.  One problem with the size of this fragment is that it most 
likely does not contain both pqsDE and phnAB.  If the transcript only contains pqsDE, it 
would call into question our RT-PCR results and exactly how the transcript is 
upregulated.  Future efforts are underway to understand exactly what is causing the RT-
PCR results, the stability of the PQS biosynthetic locus genes, and the size of these 
transcripts 
The next step to understanding the quantitative real-time PCR and Northern blot 
results for pqsD and pqsE was to determine if the G1041A mutation resulted in the 
creation of a new promoter.  We made two lacZ fusions, one with wild-type sequence 
and the other with G1041A mutant sequence extending 500 nucleotides upstream from 
the pqsD start codon, and β-gal activity of the G1041A fusion was significantly 
increased compared to the wild-type fusion (Figure 3.6).  The result from the β-gal 
assay taken together with both our real-time PCR and Northern results indicated that 
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the G1041A at nucleotide 1041 of pqsC resulted in the expression of a new transcript.  
This result explains the upregulation of pyocyanin (Figure 3.1) and the potential 
upregulation of phnA(B) (3.2), if pqsE and phnA(B) are indeed transcribed together.  
The upregulation of just the final two genes of the PQS biosynthetic operon and phnAB 
would be important for P. aeruginosa to circumvent the need for PQS and PqsR to drive 
the transcription of both pqsABCDE and phnAB.  This would allow for the anthranilate 
produced from the transcription of just pqsDE and phnAB to provide for tryptophan and 
other cellular functions, rather than for the production of PQS.  Furthermore, PqsE is 
known to regulate virulence factors independent of PQS production and to affect the 
expression of 90% of genes regulated by PqsR (38, 46).  The expression of just pqsDE 
and phnAB would allow the bacteria to regulate virulence factors independently of PQS 
production and to produce anthranilate for basic cellular functions.  We are currently 
undertaking experiments to identify the location of the start site in the newly identified 
transcript, as well as looking into the regulation of this transcript.  
  
CHAPTER FOUR: GENERAL SUMMARY   
 The goal of these studies was to understand the regulation of the pathways that 
produce anthranilate for PQS production in P. aeruginosa.  These investigations were 
motivated by previous data which indicated that both the kynurenine pathway and the 
secondary anthranilate synthase PhnAB were important for the production of PQS (37).  
This work revealed that the systems are utilized during different growth conditions, with 
the kynurenine pathway being the main source of anthranilate for PQS production 
during growth in complex media and PhnAB being the main source of anthranilate for 
PQS production during growth in minimal media without tryptophan (Figure 1.5)(37).  
Most bacteria do not possess the kynurenine pathway or a secondary anthranilate 
synthase, yet P. aeruginosa encodes each set of unique genes and utilizes each of the 
pathways.  The maintenance of redundant pathways for the production of anthranilate 
implies the importance of this branch point molecule to P. aeruginosa survival.  
 The kynurenine pathway functions as the main source of anthranilate when 
tryptophan, or its breakdown products are available.  The kynurenine pathway has only 
been identified in a small number of sequenced bacteria (Gram negative bacteria are 
listed in Figure 2.1), and P. aeruginosa contains only the anthranilate branch of this 
pathway, which catabolizes tryptophan into anthranilate.  This pathway provides P. 
aeruginosa with a growth advantage as P. aeruginosa could deplete this essential 
amino acid from the intra- and extracellular environments.  The kynurenine pathway 
genes are upregulated by the transcriptional regulator KynR in the presence of the co-
inducer kynurenine (Figures 2.3, 2.4, and 2.5).  Use of the pathway intermediate 
kynurenine as the co-inducer for KynR ensures that tryptophan is not catabolized unless 
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kynurenine is present and provides a check-point to ensure tryptophan concentrations 
for protein synthesis are maintained.  It has also been shown that the kynurenine 
pathway genes kynBU are upregulated by LasR.  LasR activates kynBU transcriptional 
activity (Figure 2.3) and directly binds to the intergenic region between kynB and kynR 
(43).  The induction of kynBU by LasR would allow for this pathway to be active once P. 
aeruginosa cell density has reached a quorum.  This would ensure that the kynurenine 
pathway would be primed for upregulation when P. aeruginosa encounters the 
intermediate molecule kynurenine.  Further studies need to be conducted to understand 
the availability of kynurenine during infection to determine if this pathway is critical for 
PQS production during P. aeruginosa infections, as this pathway is highly dependent on 
its presence to upregulate the transcription of the kynurenine pathway genes.   
The understanding of kynR regulation is in its infancy, as we know very little 
about how this gene is regulated.  We have constructed a transcriptional lacZ fusion of 
kynR and performed β-gal assays in multiple mutants (Figure 4.1).  Our data suggest 
that kynR is not autoregulated, unlike many feast/famine regulatory proteins, as the 
transcription of kynR is only slightly increased in a kynR mutant (Figure 4.1) (135).  We 
also looked at the quorum sensing regulators LasR and RhlR because as stated above, 
LasR was shown to bind in the intergenic region between kynBU and kynR (43).  The 
transcriptional activity of kynR is slightly increased in both lasR and rhlR mutants 
suggesting a slight negative effect on kynR transcription (Figure 4.1).  The regulation of 
kynR has not been noted in any published microarray data.  Even the catabolite   
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Figure 4.1: The transcription of kynR is minimally affected by itself or the AHL quorum 
sensing regulators.  The kynR transcriptional lacZ fusion pkynRTcZ activity was 
monitored in the P. aeruginosa strains PAO1 (black bar), kynR mutant strain PAΔKynR 
(white bar), lasR mutant strain PAOR-1 (grey bar), kynR, lasR double mutant 
PAOR1ΔKynR (horizontal striped), and rhlR mutant PJF-RLR1 (diagonal striped).  The 
cultures were assayed for β-gal activity after 24 hours growth in LB at 37°C, which is 
presented in Miller units as the mean ± σn-1 of results from at least two experiments.  
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control system CbrAB/Crc that plays a role in the regulation of other amino acid 
catabolism pathways did not influence kynR transcription (108).  To find any direct 
regulators of kynR we plan to incubate the kynR promoter with cell lysate and then elute 
off any protein that may bind to the promoter.  We can then utilize mass 
spectrophotometry to identify the bound proteins.  This technique will identify any 
proteins that directly bind to the intergenic region between kynR and kynBU and we can 
begin to investigate if and how they regulate kynR.  
Originally, the secondary anthranilate synthase PhnAB was believed to be the 
main source of anthranilate for PQS production due to its location and regulation (37).  
However, PhnAB is unable to provide anthranilate for the production of PQS when 
grown in complex media in the absence of the kynurenine pathway (37).  This was 
perplexing as phnAB is transcribed during growth in complex media (13).  We believe 
the inability of PhnAB to synthesize anthranilate for PQS production under complex 
growth conditions despite the seemingly high stationary phase transcription is due to 
potential post-translational regulation of the anthranilate synthase α-subunit, as the 
activity of anthranilate synthase α-subunits typically exhibit inhibition by tryptophan 
(100).  Essar et al. showed that tryptophan does not inhibit PhnAB activity and 
suggested that another molecule is causing this inhibition.  Furthermore, overexpression 
of a His-tagged PhnA in kynA and kynU mutants allowed for the production of PQS, 
which has been abolished in these strains (Figure 4.2).  We do not currently know what 
is causing the post-translational inhibition of PhnA and to ascertain this, our lab plans to 
first purify PhnA and then perform enzymatic assays with organic extract fractions of P.  
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Figure 4.2: The overexpression of His-tagged PhnA provides for anthranilate for PQS 
production in kynurenine pathway mutants.  Ethyl acetate extracts from cultures grown 
in LB after 24h were analyzed by TLC. Equal volumes of extracts were resolved in each 
lane.  The strains are listed below the extractions. 
  
PA
O1
 
Δk
yn
A 
Δk
yn
U 
Δp
hn
A 
PA
O1
 (p
His
Ph
nA
) 
Δk
yn
A (
pH
isP
hn
A)
 
Δk
yn
U 
(pH
isP
hn
A)
 
94 
aeruginosa culture grown in complex media.  Though this process will be time 
consuming, it will identify the post-translational inhibitory molecule of PhnA. 
Our recent research identifying a single nucleotide mutation in pqsC that induced 
the expression of pqsD, pqsE, and phnA suggested that there is a new transcript that 
starts upstream from the pqsD start codon (Figure 3.2, 3.3, and 3.5).  The single 
nucleotide change was confirmed to increase the activity of the pqsD-lacZ, that was 
shown to have a 40-fold increase in activity compared to the wild-type strain.  The next 
step in understanding the new transcript is to identify the promoter and how it is 
regulated.  The transcriptional regulator PqsR does not regulate this promoter, but we 
do not know if other quorum sensing regulators could possibly be involved in the 
regulation.  It is possible that the single nucleotide change resulted in either the relief of 
a repressor or the binding of an activator that has promoted the activation of the new 
transcript.  The benefit of this transcript for P. aeruginosa is the PQS-independent 
regulation of virulence factors, as PqsE is thought to be the main player in the quinolone 
signaling regulation cascade and has been titled the PQS response gene (31, 38, 41, 
46).  Furthermore, the creation of a new transcript that is PQS signaling independent 
would allow for dysregulation of virulence factors in P. aeruginosa, which could be 
advantageous to bacterial growth in the environment or within a host.   
 Taken together, our data have provided a better understanding of how P. 
aeruginosa regulates the pathways that provide anthranilate for PQS production, as well 
as basic cellular function.  Though a redundancy exists with multiple metabolic routes 
for anthranilate production, the unique regulation of each pathway ensures that 
anthranilate can be produced under all conditions, whether it is in feast or in famine.  
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Within the environment or during an infection, the ability of P. aeruginosa to have three 
pathways that ensure anthranilate production would be advantageous.  Anthranilate 
concentrations being high within the bacteria or environment would allow for production 
of PQS for virulence factor regulation, tryptophan production for protein synthesis, or as 
a carbon or nitrogen source.  No matter the reason, P. aeruginosa possesses the ability 
to ensure that anthranilate is produced to allow for its survival in many different 
environments.  
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